0001193125-12-404471.txt : 20120926 0001193125-12-404471.hdr.sgml : 20120926 20120926123737 ACCESSION NUMBER: 0001193125-12-404471 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20120926 DATE AS OF CHANGE: 20120926 EFFECTIVENESS DATE: 20120926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CURIAN VARIABLE SERIES TRUST CENTRAL INDEX KEY: 0001532747 IRS NUMBER: 300024958 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 333-177369 FILM NUMBER: 121110640 BUSINESS ADDRESS: STREET 1: 7601 TECHNOLOGY WAY CITY: DENVER STATE: CO ZIP: 80237 BUSINESS PHONE: (517) 367-4336 MAIL ADDRESS: STREET 1: 7601 TECHNOLOGY WAY CITY: DENVER STATE: CO ZIP: 80237 0001532747 S000035568 Curian Guidance - Maximize Income Fund C000108979 Curian Guidance - Maximize Income Fund 0001532747 S000035569 Curian Tactical Advantage 35 Fund C000108980 Curian Tactical Advantage 35 Fund 0001532747 S000035570 Curian Tactical Advantage 60 Fund C000108981 Curian Tactical Advantage 60 Fund 0001532747 S000035571 Curian Tactical Advantage 75 Fund C000108982 Curian Tactical Advantage 75 Fund 0001532747 S000035572 Curian Dynamic Risk Advantage - Diversified Fund C000108983 Curian Dynamic Risk Advantage - Diversified Fund 0001532747 S000035573 Curian Dynamic Risk Advantage - Aggressive Fund C000108984 Curian Dynamic Risk Advantage - Aggressive Fund 0001532747 S000035574 Curian Dynamic Risk Advantage - Income Fund C000108985 Curian Dynamic Risk Advantage - Income Fund 0001532747 S000035576 Curian/AQR Risk Parity Fund C000108987 Curian/AQR Risk Parity Fund 0001532747 S000035579 Curian Guidance - Balanced Income Fund C000108990 Curian Guidance - Balanced Income Fund 0001532747 S000035581 Curian/Invesco Balanced-Risk Commodities Strategy Fund C000108992 Curian/Invesco Balanced-Risk Commodities Strategy Fund 0001532747 S000035586 Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund C000108997 Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund 0001532747 S000035587 Curian Guidance - Rising Income Fund C000108998 Curian Guidance - Rising Income Fund 0001532747 S000035588 Curian Guidance - Moderate Growth Fund C000108999 Curian Guidance - Moderate Growth Fund 0001532747 S000035589 Curian Guidance - Maximum Growth Fund C000109000 Curian Guidance - Maximum Growth Fund 0001532747 S000035590 Curian Guidance - Tactical Moderate Growth Fund C000109001 Curian Guidance - Tactical Moderate Growth Fund 0001532747 S000035591 Curian Guidance - Tactical Maximum Growth Fund C000109002 Curian Guidance - Tactical Maximum Growth Fund 0001532747 S000035592 Curian Guidance - Institutional Alt 65 Fund C000109003 Curian Guidance - Institutional Alt 65 Fund 0001532747 S000035593 Curian Guidance - Institutional Alt 100 Fund C000109004 Curian Guidance - Institutional Alt 100 Fund 0001532747 S000037896 Curian Guidance - Equity 100 Fund C000116992 Curian Guidance - Equity 100 Fund 0001532747 S000037897 Curian Guidance - Fixed Income 100 Fund C000116993 Curian Guidance - Fixed Income 100 Fund 0001532747 S000037899 Curian/Franklin Templeton Frontier Markets Fund C000116995 Curian/Franklin Templeton Frontier Markets Fund 0001532747 S000037900 Curian/Neuberger Berman Currency Fund C000116996 Curian/Neuberger Berman Currency Fund 497 1 d415188d497.htm 497 497

CURIAN VARIABLE SERIES TRUST

7601 Technology Way, Denver, Colorado 80237

(877) 847-4143

September 26, 2012

Securities and Exchange Commission

450 Fifth Street, NW

Judiciary Plaza

Washington, DC 20549

 

Re: Curian Variable Series Trust

File Nos. 333-177369 and 811-22613

Dear Sir/Madam:

Pursuant to Rule 497(e) under the Securities Act of 1933, as amended, we hereby file exhibits containing interactive data format risk/return summary information that reflects the risk/return summary information in the supplement dated September 10, 2012, filed pursuant to Rule 497(e), for the following Funds, which are funds of the above mentioned Trust:

Curian Guidance – Maximize Income Fund

Curian Guidance – Balanced Income Fund

Curian Guidance – Rising Income Fund

Curian Guidance – Moderate Growth Fund

Curian Guidance – Maximum Growth Fund

Curian Guidance – Tactical Moderate Growth Fund

Curian Guidance – Tactical Maximum Growth Fund

Curian Guidance – Equity 100 Fund

Curian Guidance – Fixed Income 100 Fund

Curian Guidance – Institutional Alt 65 Fund

Curian Guidance – Institutional Alt 100 Fund

Curian Tactical Advantage 35 Fund

Curian Tactical Advantage 60 Fund

Curian Tactical Advantage 75 Fund,

Curian Dynamic Risk Advantage – Diversified Fund

Curian Dynamic Risk Advantage – Aggressive Fund

Curian Dynamic Risk Advantage – Income Fund

Curian/AQR Risk Parity Fund

Curian/Franklin Templeton Frontier Markets Fund

Curian/Invesco Balanced-Risk Commodities Strategy Fund

Curian/Neuberger Berman Currency Fund

Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund


If you have any questions concerning this filing, please contact me at (517) 367-4336.

 

Very truly yours,

/s/ Susan S. Rhee

Susan S. Rhee

enc.

EX-101.INS 2 cvst1-20120910.xml XBRL INSTANCE DOCUMENT 0001532747 2011-05-01 2012-04-30 0001532747 cvst1:S000035573Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035568Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035569Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035570Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035571Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035572Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035587Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035588Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035589Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035591Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035592Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035593Member 2011-05-01 2012-04-30 0001532747 cvst1:S000037897Member 2011-05-01 2012-04-30 0001532747 cvst1:S000037900Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035576Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035574Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035579Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035581Member 2011-05-01 2012-04-30 0001532747 cvst1:S000037899Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035586Member 2011-05-01 2012-04-30 0001532747 cvst1:S000035590Member 2011-05-01 2012-04-30 0001532747 cvst1:S000037896Member 2011-05-01 2012-04-30 CURIAN VARIABLE SERIES TRUST Other 2011-12-31 0001532747 false 2012-09-10 2012-04-30 2012-09-10 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the summary prospectus for the Curian/Franklin Templeton Frontier Markets Fund, in the section entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Principal Risks of Investing in the Fund</font>&#8221; please add the following risks:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div> </td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">China and India country specific risks </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8211; </font>Investment primarily in equity and equity-related securities in the People&#8217;s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Risks of investments in Russia </font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">&#8211;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia&#8217;s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company&#8217;s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.</font></div> </td> </tr></table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the summary prospectus for the Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund, in the section entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Principal Risks of Investing in the Fund</font>&#8221; please add the following risks:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">China and India country specific risks </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8211; </font>Investment primarily in equity and equity-related securities in the People&#8217;s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Frontier market countries risk</font> &#8211; Frontier market countries generally have smaller economies and even less developed capital markets than traditional developing markets, and, as a result, the risks of investing in developing market countries are magnified in frontier market countries. The magnification of risks are the result of: potential for extreme price volatility and illiquidity in frontier markets; government ownership or control of parts of private sector and of certain companies; trade barriers, exchange controls, managed adjustments in relative currency values and other protectionist measures imposed or negotiated by the countries with which frontier market countries trade; and the relatively new and unsettled securities laws in many frontier market countries.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Risks of investments in Russia </font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">&#8211;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia&#8217;s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company&#8217;s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.</font></div> </td> </tr></table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Summary Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplement Dated September 10, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Prospectus Dated April 30, 2012</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Curian Variable Series Trust</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Curian Guidance &#8211; Maximize Income Fund, Curian Guidance &#8211; Balanced Income Fund, Curian Guidance &#8211; Rising Income Fund, Curian Guidance &#8211; Moderate Growth Fund, Curian Guidance &#8211; Maximum Growth Fund, Curian Guidance &#8211; Tactical Moderate Growth Fund, Curian Guidance &#8211; Tactical Maximum Growth Fund, Curian Guidance &#8211; Equity 100 Fund, Curian Guidance &#8211; Fixed Income 100 Fund, Curian Guidance &#8211; Institutional Alt 65 Fund, Curian Guidance &#8211; Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage &#8211; Diversified Fund, Curian Dynamic Risk Advantage &#8211; Aggressive Fund, Curian Dynamic Risk Advantage &#8211; Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">counterparty and settlement risk</font>&#8221; in its entirety and replace it with the following:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><tr valign="top"><td style="TEXT-ALIGN: center; WIDTH: 36pt"><div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div></td></tr></table></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the summary prospectus for the Curian/Franklin Templeton Frontier Markets Fund, in the section entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Principal Risks of Investing in the Fund</font>&#8221; please add the following risks:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div> </td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">China and India country specific risks </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8211; </font>Investment primarily in equity and equity-related securities in the People&#8217;s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Risks of investments in Russia </font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">&#8211;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia&#8217;s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company&#8217;s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.</font></div> </td> </tr></table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 4.5pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the summary prospectus for the Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund, in the section entitled &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Principal Risks of Investing in the Fund</font>&#8221; please add the following risks:</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br/> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">China and India country specific risks </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8211; </font>Investment primarily in equity and equity-related securities in the People&#8217;s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Counterparty and settlement risk</font><font style="DISPLAY: inline; FONT-WEIGHT: bold"> &#8211; </font>Trading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Frontier market countries risk</font> &#8211; Frontier market countries generally have smaller economies and even less developed capital markets than traditional developing markets, and, as a result, the risks of investing in developing market countries are magnified in frontier market countries. The magnification of risks are the result of: potential for extreme price volatility and illiquidity in frontier markets; government ownership or control of parts of private sector and of certain companies; trade barriers, exchange controls, managed adjustments in relative currency values and other protectionist measures imposed or negotiated by the countries with which frontier market countries trade; and the relatively new and unsettled securities laws in many frontier market countries.</font></div> </td> </tr></table> </div> <div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: center; WIDTH: 36pt"> <div style="TEXT-ALIGN: center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal">&#9679;</font></font></div></td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Risks of investments in Russia </font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">&#8211;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia&#8217;s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company&#8217;s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.</font></div> </td> </tr></table></div> EX-101.SCH 3 cvst1-20120910.xsd XBRL TAXONOMY EXTENSION SCHEMA 000000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 000011 - Document - Risk/Return Summary {Unlabeled} - Curian Dynamic Risk Advantage - Aggressive Fund link:presentationLink link:calculationLink link:definitionLink 000012 - Schedule - Shareholder Fees - Curian Dynamic Risk Advantage - Aggressive Fund link:presentationLink link:calculationLink link:definitionLink 000013 - Schedule - Annual Fund Operating Expenses - Curian Dynamic Risk Advantage - Aggressive Fund link:presentationLink link:calculationLink link:definitionLink 000014 - Schedule - Expense Example {Transposed} - Curian Dynamic Risk Advantage - Aggressive Fund link:presentationLink link:calculationLink link:definitionLink 000015 - Schedule - Expense Example, No Redemption {Transposed} - Curian Dynamic Risk Advantage - Aggressive Fund link:presentationLink link:calculationLink link:definitionLink 000016 - Schedule - Annual Total Returns - Curian Dynamic Risk Advantage - Aggressive Fund [BarChart] link:presentationLink link:calculationLink link:definitionLink 000017 - Schedule - Average Annual Total Returns {Transposed} - Curian Dynamic Risk Advantage - Aggressive Fund link:presentationLink link:calculationLink link:definitionLink 000018 - Document - Risk/Return Detail {Unlabeled} - Curian Dynamic Risk Advantage - Aggressive Fund link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - Risk/Return Detail Data {Elements} - CURIAN VARIABLE SERIES TRUST link:presentationLink link:calculationLink link:definitionLink 000010 - Document - Risk/Return Supplement {Unlabeled} - CURIAN VARIABLE SERIES TRUST link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 cvst1-20120910_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 5 cvst1-20120910_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 cvst1-20120910_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 7 cvst1-20120910_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } EXCEL 9 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\U9C(V.3!C85\Q96)D7S1A8F9?8F9A,5\W,31D M9&8P,&0T96(B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O M=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D M/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D M('=I=&@@36EC'1087)T7S5F,C8Y,&-A7S%E M8F1?-&%B9E]B9F$Q7S'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^0U5224%.(%9!4DE!0DQ%(%-%4DE%4R!44E535#QS<&%N M/CPO'0^4V5P(#$P+`T*"0DR,#$R M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^4V5P(#$P+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G/D9O&EM=6T@1W)O=W1H($9U;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N M($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@ M0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P M($9U;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD+"!A M;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE)SY#;W5N=&5R<&%R='D@86YD('-E='1L96UE;G0@3X\9F]N="!S='EL93TS1"=&3TY4 M+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`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`F(S@R,3$[(#PO9F]N=#Y46QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M(#QT6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@ M1$E34$Q!63H@:6YL:6YE.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG M;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE)SY2:7-K6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,X,C$Q.SPO9F]N=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD M)SXF(S$V,#L\+V9O;G0^02!&=6YD(&UA>2!I;G9E2!E>'1R86-T2X@06QS;RP@=&AE'1R86-T2!O;B!R96=I M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#0N-7!T)R!A;&EG;CTS1&IU6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M(#QT6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@ M1$E34$Q!63H@:6YL:6YE.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY2:7-K6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,X,C$Q.SPO9F]N=#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD)SXF(S$V,#L\+V9O;G0^02!& M=6YD(&UA>2!I;G9E2!E>'1R86-T M2!S=6)J96-T('1O(&5F9F5C=&EV92!S=&%T92!S=7!E2X@06QS;RP@=&AE'1R86-T2!O;B!R96=I2!H M879E(&%G86EN7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^0U5224%.(%9!4DE!0DQ%(%-% M4DE%4R!44E535#QS<&%N/CPO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0G/D9O&EM=6T@ M1W)O=W1H($9U;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E M("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U M:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U M6YA;6EC(%)I6YA M;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N M+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS M1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE)SY#;W5N=&5R<&%R='D@86YD('-E='1L96UE;G0@3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I M=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`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`F(S@R M,3$[(#PO9F]N=#Y46QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^(#QT6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY2 M:7-K6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,X,C$Q.SPO9F]N=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD)SXF(S$V,#L\ M+V9O;G0^02!&=6YD(&UA>2!I;G9E2!E>'1R86-T2X@06QS;RP@=&AE'1R86-T2!O;B!R96=I2!H879E(&%G86EN6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#0N-7!T M)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^(#QT6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY# M:&EN82!A;F0@26YD:6$@8V]U;G1R>2!S<&5C:69I8R!R:7-K'!O2!T;R!T:&5I6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE'1R96UE('!R:6-E('9O;&%T:6QI='D@86YD(&EL M;&EQ=6ED:71Y(&EN(&9R;VYT:65R(&UA2!T:&4@8V]U;G1R:65S M('=I=&@@=VAI8V@@9G)O;G1I97(@;6%R:V5T(&-O=6YT6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^(#QT6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+5-)6D4Z M(#$P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY2:7-K6QE/3-$)T9/3E0M4U193$4Z M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,X,C$Q.SPO9F]N=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M5T5)1TA4.B!B;VQD)SXF(S$V,#L\+V9O;G0^02!&=6YD(&UA>2!I M;G9E2!E>'1R86-T2!S=6)J96-T('1O(&5F9F5C=&EV92!S=&%T92!S=7!E2X@06QS;RP@=&AE2!R96-O'1R86-T2!O;B!R96=I2!H879E(&%G86EN MF4@26YC;VUE($9U;F0\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&@^8W9S=#%?4W5P<&QE;65N=%1E>'1";&]C:SPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/ M3E0M5D%224%.5#H@6QE/3-$ M)T9/3E0M5D%224%.5#H@2!06QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO M9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV/B`\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@ M3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY&;W(@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@ M36%X:6UI>F4@26YC;VUE($9U;F0L($-U6YA M;6EC(%)I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/F-O M=6YT97)P87)T>2!A;F0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^/'1R('9A;&EG;CTS1'1O<#X\=&0@6QE/3-$)T9/3E0M4U193$4Z M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+5-)6D4Z(#$P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0G/D9O&EM=6T@1W)O M=W1H($9U;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C M.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U:61A M;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U6YA;6EC(%)I6YA;6EC M(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE M=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU M6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE M)SY#;W5N=&5R<&%R='D@86YD('-E='1L96UE;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^/&9O;G0@&EM=6T@1W)O=W1H($9U;F0L($-U&5D($EN8V]M M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I M;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS M=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;W5N=&5R<&%R='D@ M86YD('-E='1L96UE;G0@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6QE/3-$)T9/3E0M5D%224%. M5#H@6QE/3-$)T9/3E0M5D%2 M24%.5#H@6QE/3-$)T9/3E0M5D%224%.5#H@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV/B`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#0N-7!T)R!A;&EG M;CTS1&IU&EM=6T@1W)O=W1H($9U;F0L M($-U2`Q,#`@1G5N9"P@0W5R M:6%N($=U:61A;F-E("8C.#(Q,3L@1FEX960@26YC;VUE(#$P,"!&=6YD+"!# M=7)I86X@1W5I9&%N8V4@)B,X,C$Q.R!);G-T:71U=&EO;F%L($%L="`V-2!& M=6YD+"!#=7)I86X@1W5I9&%N8V4@)B,X,C$Q.R!);G-T:71U=&EO;F%L($%L M="`Q,#`@1G5N9"P@0W5R:6%N(%1A8W1I8V%L($%D=F%N=&%G92`S-2!&=6YD M+"!#=7)I86X@5&%C=&EC86P@061V86YT86=E(#8P($9U;F0L($-U2!&=6YD+"!#=7)I86XO M26YV97-C;R!"86QA;F-E9"U2:7-K($-O;6UO9&ET:65S(%-T2!&=6YD M+"!P;&5A2!A;F0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV/B`\9&EV/CQT M86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$ M,3`P)2!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A;F0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0G/B`F(S@R,3$[(#PO9F]N=#Y46QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0G/D9O&EM=6T@ M1W)O=W1H($9U;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E M("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U M:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U M6YA;6EC(%)I6YA M;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N M+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS M1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE)SY#;W5N=&5R<&%R='D@86YD('-E='1L96UE;G0@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T9/3E0M5D%224%.5#H@6QE/3-$)T9/3E0M5D%224%.5#H@6QE/3-$)T9/3E0M M5D%224%.5#H@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#0N-7!T)R!A;&EG;CTS1&IU&EM=6T@1W)O=W1H($9U;F0L($-U2`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q M,3L@1FEX960@26YC;VUE(#$P,"!&=6YD+"!#=7)I86X@1W5I9&%N8V4@)B,X M,C$Q.R!);G-T:71U=&EO;F%L($%L="`V-2!&=6YD+"!#=7)I86X@1W5I9&%N M8V4@)B,X,C$Q.R!);G-T:71U=&EO;F%L($%L="`Q,#`@1G5N9"P@0W5R:6%N M(%1A8W1I8V%L($%D=F%N=&%G92`S-2!&=6YD+"!#=7)I86X@5&%C=&EC86P@ M061V86YT86=E(#8P($9U;F0L($-U2!&=6YD+"!#=7)I86XO26YV97-C;R!"86QA;F-E9"U2 M:7-K($-O;6UO9&ET:65S(%-T2!&=6YD+"!P;&5A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(O/CPO9&EV/B`\9&EV/CQT86)L92!C96QL<&%D9&EN9STS M1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE2!A;F0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G M/B`F(S@R,3$[(#PO9F]N=#Y46QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^/&9O;G0@&EM=6T@1W)O=W1H($9U M;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@ M26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C M.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;W5N M=&5R<&%R='D@86YD('-E='1L96UE;G0@2`Q,#`@1G5N9#PO M=&0^#0H@("`@("`@(#QT9"!C;&%S6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@ M6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D9O&EM=6T@1W)O=W1H($9U;F0L($-U&5D($EN8V]M92`Q,#`@1G5N M9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@ M-C4@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA M;"!!;'0@,3`P($9U;F0L($-U6YA;6EC M(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;W5N=&5R<&%R='D@86YD('-E='1L M96UE;G0@&5D($EN8V]M92`Q,#`@1G5N9#PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q! M63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0G/D9O&EM=6T@1W)O=W1H($9U;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N($=U M:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@0W5R M:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P($9U M;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@ M0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A M;&EG;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q! M63H@:6YL:6YE)SY#;W5N=&5R<&%R='D@86YD('-E='1L96UE;G0@'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&@^8W9S=#%? M4W5P<&QE;65N=%1E>'1";&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M5D%224%.5#H@ M6QE/3-$)T9/3E0M5D%224%. M5#H@2!06QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV/B`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K)SX\8G(O/CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@3X\9F]N M="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY&;W(@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@36%X:6UI>F4@26YC M;VUE($9U;F0L($-U6YA;6EC(%)I6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/F-O=6YT97)P87)T>2!A M;F0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M/'1R('9A;&EG;CTS1'1O<#X\=&0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^/&9O;G0@&EM=6T@1W)O=W1H($9U M;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@ M26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C M.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;W5N M=&5R<&%R='D@86YD('-E='1L96UE;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@ M6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D9O&EM=6T@1W)O=W1H($9U;F0L($-U&5D($EN8V]M92`Q,#`@1G5N M9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@ M-C4@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA M;"!!;'0@,3`P($9U;F0L($-U6YA;6EC M(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;W5N=&5R<&%R='D@86YD('-E='1L M96UE;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0G/D9O&EM=6T@ M1W)O=W1H($9U;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E M("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U M:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U M6YA;6EC(%)I6YA M;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N M+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS M1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE)SY#;W5N=&5R<&%R='D@86YD('-E='1L96UE;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^/&9O;G0@&EM=6T@1W)O=W1H($9U;F0L($-U&5D($EN8V]M M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I M;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS M=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;W5N=&5R<&%R='D@ M86YD('-E='1L96UE;G0@6YA;6EC(%)I6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O M;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M/&9O;G0@&EM=6T@1W)O=W1H($9U;F0L($-U&5D($EN8V]M92`Q M,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA M;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET M=71I;VYA;"!!;'0@,3`P($9U;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4U19 M3$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;W5N=&5R<&%R='D@86YD M('-E='1L96UE;G0@6YA;6EC(%)I'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$)T9/3E0M M5D%224%.5#H@6QE/3-$)T9/ M3E0M5D%224%.5#H@6QE/3-$)T9/3E0M5D%224%.5#H@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO M9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#0N-7!T M)R!A;&EG;CTS1&IU&EM=6T@1W)O=W1H M($9U;F0L($-U2`Q,#`@1G5N M9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@1FEX960@26YC;VUE(#$P,"!& M=6YD+"!#=7)I86X@1W5I9&%N8V4@)B,X,C$Q.R!);G-T:71U=&EO;F%L($%L M="`V-2!&=6YD+"!#=7)I86X@1W5I9&%N8V4@)B,X,C$Q.R!);G-T:71U=&EO M;F%L($%L="`Q,#`@1G5N9"P@0W5R:6%N(%1A8W1I8V%L($%D=F%N=&%G92`S M-2!&=6YD+"!#=7)I86X@5&%C=&EC86P@061V86YT86=E(#8P($9U;F0L($-U M2!&=6YD+"!# M=7)I86XO26YV97-C;R!"86QA;F-E9"U2:7-K($-O;6UO9&ET:65S(%-T2!&=6YD+"!P;&5A2!A;F0@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV/B`\ M9&EV/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('=I M9'1H/3-$,3`P)2!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E3X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A;F0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/B`F(S@R,3$[(#PO9F]N=#Y46QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@ M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0G/D9O&EM=6T@1W)O=W1H($9U;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R M:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N M9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@ M,3`P($9U;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD M+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@ M1$E34$Q!63H@:6YL:6YE)SY#;W5N=&5R<&%R='D@86YD('-E='1L96UE;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^/&9O;G0@&EM=6T@1W)O=W1H($9U;F0L M($-U&5D M($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@26YS M=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q M,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$ M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;W5N=&5R M<&%R='D@86YD('-E='1L96UE;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^/&9O;G0@&EM=6T@1W)O=W1H($9U M;F0L($-U&5D($EN8V]M92`Q,#`@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C.#(Q,3L@ M26YS=&ET=71I;VYA;"!!;'0@-C4@1G5N9"P@0W5R:6%N($=U:61A;F-E("8C M.#(Q,3L@26YS=&ET=71I;VYA;"!!;'0@,3`P($9U;F0L($-U6YA;6EC(%)I6YA;6EC(%)I2!&=6YD+"!A;F0@0W5R:6%N+TYE=6)E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;W5N M=&5R<&%R='D@86YD('-E='1L96UE;G0@'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&@^8W9S=#%?4W5P<&QE;65N=%1E>'1";&]C:SPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT M('-T>6QE/3-$)T9/3E0M5D%224%.5#H@6QE/3-$)T9/3E0M5D%224%.5#H@2!06QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K)SX\8G(O/CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV/B`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^/&9O;G0@3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q% M.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W(@0W5R:6%N($=U:61A M;F-E("8C.#(Q,3L@36%X:6UI>F4@26YC;VUE($9U;F0L($-U6YA;6EC(%)I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E' M2%0Z(&)O;&0G/F-O=6YT97)P87)T>2!A;F0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^/'1R('9A;&EG;CTS1'1O<#X\=&0@ M6QE/3-$ M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+5-) M6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@ M6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV M/CQD:78@3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L M:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);B!T:&4@2!P6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^(#QT6QE/3-$)T9/3E0M M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+5-)6D4Z(#$P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&YO6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/B8C.#(Q,3L@/"]F;VYT M/DEN=F5S=&UE;G0@<')I;6%R:6QY(&EN(&5Q=6ET>2!A;F0@97%U:71Y+7)E M;&%T960@2P@86YD(&]T M:&5R(')I2!A;F0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E3X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M2!A;F0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/B`F(S@R,3$[ M(#PO9F]N=#Y46QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^(#QT6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY2:7-K M6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+5=%24=(5#H@8F]L9"<^)B,X,C$Q.SPO9F]N=#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD)SXF(S$V,#L\+V9O M;G0^02!&=6YD(&UA>2!I;G9E2!E M>'1R86-T2X@06QS;RP@=&AE'1R86-T2!O;B!R96=I2!H879E(&%G86EN'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&@^8W9S=#%?4W5P<&QE;65N=%1E>'1";&]C:SPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M M5D%224%.5#H@6QE/3-$)T9/ M3E0M5D%224%.5#H@2!06QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV M/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K)SX\8G(O/CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G/DEN('1H92!S=6UM87)Y('!R;W-P96-T=7,@9F]R M('1H92!#=7)I86XO5&AE($)O6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(O/B`\+V1I=CX@ M(#QD:78^(#QT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P M('=I9'1H/3-$,3`P)2!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/B8C.#(Q M,3L@/"]F;VYT/DEN=F5S=&UE;G0@<')I;6%R:6QY(&EN(&5Q=6ET>2!A;F0@ M97%U:71Y+7)E;&%T960@2P@86YD(&]T:&5R(')I2!A;F0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE2!A;F0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G M/B`F(S@R,3$[(#PO9F]N=#Y46QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^(#QT M6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($U!4D=)3BU,1494.B`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`T*"0DR,#$R M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^ M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U9C(V M.3!C85\Q96)D7S1A8F9?8F9A,5\W,31D9&8P,&0T96(-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-68R-CDP8V%?,65B9%\T86)F7V)F83%?-S$T M9&1F,#!D-&5B+U=O&UL#0I#;VYT96YT+51R M86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y M<&4Z('1E>'0O:'1M;#L@8VAA&UL M;G,Z;STS1")U&UL/@T*+2TM+2TM/5].97AT4&%R=%\U9C(V.3!C85\Q96)D7S1A 88F9?8F9A,5\W,31D9&8P,&0T96(M+0T* ` end XML 10 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.


In the summary prospectus for the Curian/Franklin Templeton Frontier Markets Fund, in the section entitled “Principal Risks of Investing in the Fund” please add the following risks:

China and India country specific risks Investment primarily in equity and equity-related securities in the People’s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.
Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Risks of investments in Russia  A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia’s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company’s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.


In the summary prospectus for the Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund, in the section entitled “Principal Risks of Investing in the Fund” please add the following risks:

China and India country specific risks Investment primarily in equity and equity-related securities in the People’s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.
Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Frontier market countries risk – Frontier market countries generally have smaller economies and even less developed capital markets than traditional developing markets, and, as a result, the risks of investing in developing market countries are magnified in frontier market countries. The magnification of risks are the result of: potential for extreme price volatility and illiquidity in frontier markets; government ownership or control of parts of private sector and of certain companies; trade barriers, exchange controls, managed adjustments in relative currency values and other protectionist measures imposed or negotiated by the countries with which frontier market countries trade; and the relatively new and unsettled securities laws in many frontier market countries.
Risks of investments in Russia  A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia’s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company’s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.
XML 11 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 12 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Registrant Name dei_EntityRegistrantName CURIAN VARIABLE SERIES TRUST
Prospectus Date rr_ProspectusDate Apr. 30, 2012
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.


In the summary prospectus for the Curian/Franklin Templeton Frontier Markets Fund, in the section entitled “Principal Risks of Investing in the Fund” please add the following risks:

China and India country specific risks Investment primarily in equity and equity-related securities in the People’s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.
Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Risks of investments in Russia  A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia’s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company’s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.


In the summary prospectus for the Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund, in the section entitled “Principal Risks of Investing in the Fund” please add the following risks:

China and India country specific risks Investment primarily in equity and equity-related securities in the People’s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.
Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Frontier market countries risk – Frontier market countries generally have smaller economies and even less developed capital markets than traditional developing markets, and, as a result, the risks of investing in developing market countries are magnified in frontier market countries. The magnification of risks are the result of: potential for extreme price volatility and illiquidity in frontier markets; government ownership or control of parts of private sector and of certain companies; trade barriers, exchange controls, managed adjustments in relative currency values and other protectionist measures imposed or negotiated by the countries with which frontier market countries trade; and the relatively new and unsettled securities laws in many frontier market countries.
Risks of investments in Russia  A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia’s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company’s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.
Curian Guidance - Maximize Income Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Balanced Income Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Rising Income Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Moderate Growth Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Maximum Growth Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Tactical Moderate Growth Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Tactical Maximum Growth Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Equity 100 Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Fixed Income 100 Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Institutional Alt 65 Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Guidance - Institutional Alt 100 Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Tactical Advantage 35 Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Tactical Advantage 60 Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Tactical Advantage 75 Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Dynamic Risk Advantage - Diversified Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Dynamic Risk Advantage - Aggressive Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian Dynamic Risk Advantage - Income Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian/AQR Risk Parity Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian/Invesco Balanced-Risk Commodities Strategy Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian/Neuberger Berman Currency Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

For Curian Guidance – Maximize Income Fund, Curian Guidance – Balanced Income Fund, Curian Guidance – Rising Income Fund, Curian Guidance – Moderate Growth Fund, Curian Guidance – Maximum Growth Fund, Curian Guidance – Tactical Moderate Growth Fund, Curian Guidance – Tactical Maximum Growth Fund, Curian Guidance – Equity 100 Fund, Curian Guidance – Fixed Income 100 Fund, Curian Guidance – Institutional Alt 65 Fund, Curian Guidance – Institutional Alt 100 Fund, Curian Tactical Advantage 35 Fund, Curian Tactical Advantage 60 Fund, Curian Tactical Advantage 75 Fund, Curian Dynamic Risk Advantage – Diversified Fund, Curian Dynamic Risk Advantage – Aggressive Fund, Curian Dynamic Risk Advantage – Income Fund, Curian/AQR Risk Parity Fund, Curian/Invesco Balanced-Risk Commodities Strategy Fund, and Curian/Neuberger Berman Currency Fund, please delete the risk entitled “counterparty and settlement risk” in its entirety and replace it with the following:

Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Curian/Franklin Templeton Frontier Markets Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

In the summary prospectus for the Curian/Franklin Templeton Frontier Markets Fund, in the section entitled “Principal Risks of Investing in the Fund” please add the following risks:

China and India country specific risks Investment primarily in equity and equity-related securities in the People’s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.
Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Risks of investments in Russia  A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia’s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company’s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.
Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] cvst1_SupplementTextBlock
Supplement Dated September 10, 2012
To The Summary Prospectus Dated April 30, 2012

Supplement Dated September 10, 2012
To The Prospectus Dated April 30, 2012

Curian Variable Series Trust

In the summary prospectus for the Curian/The Boston Company Multi-Alpha Market Neutral Equity Fund, in the section entitled “Principal Risks of Investing in the Fund” please add the following risks:

China and India country specific risks Investment primarily in equity and equity-related securities in the People’s Republic of China and India will expose, the Fund specifically to their market, currency, and other risks, including volatility and structural risks.
Counterparty and settlement riskTrading options, futures contracts and other derivative financial instruments, as well as, certain over-the-counter securities entails credit and settlement risk on the counterparties.
Frontier market countries risk – Frontier market countries generally have smaller economies and even less developed capital markets than traditional developing markets, and, as a result, the risks of investing in developing market countries are magnified in frontier market countries. The magnification of risks are the result of: potential for extreme price volatility and illiquidity in frontier markets; government ownership or control of parts of private sector and of certain companies; trade barriers, exchange controls, managed adjustments in relative currency values and other protectionist measures imposed or negotiated by the countries with which frontier market countries trade; and the relatively new and unsettled securities laws in many frontier market countries.
Risks of investments in Russia  A Fund may invest a portion of its assets in securities issued by companies located in Russia. Because of the recent formation of the Russian securities markets as well as the underdeveloped state of Russia’s banking system, settlement, clearing and registration of securities transactions are subject to significant risks. Ownership of shares is defined according to entries in the company’s share register and normally evidenced by extracts from the register. The registrars are not necessarily subject to effective state supervision nor are they licensed with any governmental entity. Also, there is no central registration system for shareholders and it is possible for a Fund to lose its registration through fraud, negligence or mere oversight. While a Fund will endeavor to ensure that its interest continues to be appropriately recorded either itself or through a custodian or other agent inspecting the share register and by obtaining extracts of share registers through regular confirmations, these extracts have no legal enforceability and it is possible that subsequent illegal amendment or other fraudulent act may deprive the Fund of its ownership rights or improperly dilute its interest. In addition, while applicable Russian regulations impose liability on registrars for losses resulting from their errors, it may be difficult for a Fund to enforce any rights it may have against the registrar or issuer of the securities in the event of loss of share registration. While a Fund intends to invest directly in Russian companies that use an independent registrar, there can be no assurance that such investments will not result in a loss to the Fund.
XML 13 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
12 Months Ended
Apr. 30, 2012
Risk/Return:  
Document Type Other
Document Period End Date Dec. 31, 2011
Registrant Name CURIAN VARIABLE SERIES TRUST
Central Index Key 0001532747
Amendment Flag false
Document Creation Date Sep. 10, 2012
Document Effective Date Sep. 10, 2012
Prospectus Date Apr. 30, 2012
XML 14 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Registrant Name dei_EntityRegistrantName CURIAN VARIABLE SERIES TRUST
Prospectus Date rr_ProspectusDate Apr. 30, 2012
Document Creation Date dei_DocumentCreationDate Sep. 10, 2012
ZIP 15 0001193125-12-404471-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-12-404471-xbrl.zip M4$L#!!0````(`+ED.D'-\B91/1$``*C_`0`2`!P`8W9S=#$M,C`Q,C`Y,3`N M>&UL550)``->+V-07B]C4'5X"P`!!"4.```$.0$``.V=75/CR!6&[U.5_]`A ME;W"V(8!8V`VQ0PP<078"9#L)C=;;:EM]XXL*=V2P?GU.:=;\@=?"[/LKF2_ MM1<[R/UY^O2K:FT(%0=)J./A^XW<-J0-M-[X MZ[=__,/1GQJ-'SYM!LWM[>;OTD@R\VB;>"9-S<;K6W6]TV#=:7OK-ZJ>SMSE9BAE2L MU6[^<'%^'8S46#9T3#W&@2IKA6I>B[O>LBK8&B:3)GW@NFBTVHV==EGZ,I"N\U_8=E46V3=]OMSC.-%R5F M;3\82V&>=K?;;;I/BZ+/M5G:CM9)B".N=&"=6:_40+A&#K)IJMYO6#U.(YZ8 MNS8R:O!^PZUFHURUK3L;;HBF;RE(R!7N,J'#]QLGN9$9.>*/K?:%G%+Q]H\[ MK>/4<$7?,54@S]/9M/B+_M8A7QEH980;D%J:1;E('WM_W_BV1?ZPN[/=>=XK\ZL;B&V@AKSS9Q?HDG?. M`W671CK0F1^+"#65\YI"F^G@7`UE=.K&=7RG[<:WSB$.YG/PU8Z:C[8V[[^Y M/(":+MG>?OV7;&]_O9:LNP)+UEVK)>NTZK]DG=9Z+5E[!9:LO5Y+MKT"2[:] M5DNVWZG_DNUWUFO)5B!BW%^OB'%_!2+&_?6*&+LK$'YTURO\Z*Y`^-%=K_"C MNP+`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`QXD493;]!^^,O&LE#?OYF5HIPY48Y)E`V+\FQ(F1&3XBZ0)>G\/S MWJ?+`^'OR8?B^][)S=\.Q,Y>(>:/V6.IRB^\L]R[=SS74)R07T8;\]7O[G6Z MAP^7\K%U=?_.PKD-GIK;TEJ_)JAY[D;[!C?5K["P#W!>M:F^;N,NB=92@S=& MLJ.+)&6IMYMBD&5O%Y/^/39]D<1. M&A:TARINO=2/FIF9_Y.W]_WR1\TGP<9;U32 MYN`>X![@'N`>X![@'N`>X![@'N`>=>4>77`/I)7@'E6R/1P4W*.2-@?W`/<` M]P#W`/<`]P#W`/<`]P#WJ"GW6'@I[;I$[T@KP3TJ;7LX*+A')6T.[@'N`>X! M[@'N`>X![@'N`>X![E%7[M$&]T!:">Y1)=O#0<$]*FES<`]P#W`/<`]P#W`/ M<`]P#W`/<(^Z`>5;(]'!3H*??8[X![(*T$]ZB2[>&@X!Z5M#FX![@'N`>X![@'N`>X![@'N`>X1UVY M!W[/!6DEN$>E;`\'!?>HI,W!/<`]P#W`/<`]P#W`/<`]P#W`/>K*/?![+D@K MP3TJ97LX*+A')6T.[@'N`>X![@'N`>X![@'N`>X![E%3[M'%>TV15H)[5,KV M<%!PCTK:'-P#W`/<`]P#W`/<`]P#W`/<`]RCKMP#[S5%6@GN42G;PT'!/2II MS@HN$X![@'N M`>X![@'N`>X![@'N44_NT6VUP#V05H)[5,GV<%!PCTK:'-P#W`/<`]P#W`/< M`]P#W`/<`]RCEMQC=[>S!^Z!M!+U32YN`>X![@'N`>X![@'N`> MX![@'N`>=>4>[\`]D%:">U3)]G!0<(]*VAS<`]P#W`/<`]P#W`/<`]P#W`/< MHZ[#@GM4TN;@'N`>X![@'N`>X![@'N`>X![@'C7E'OMM M<`^DE>`>5;(]'!3H)??H['?QO`?2 M2G"/2MD>#@KN44F;?Q7W>$-#KQ[UZ/E`PA8RF\Z]>9`8]U&1:)T9&7^A7L2- M&I,X9!2!G!D:GR91N)#FBZ*@R*=&>&"[K]B^ M3^9;?A.[>(-NGB1$.IKR?E8>`_+@_#\;1D7N)KN0+17[_K-*:'?/NN@<6G&E MTKQ/$V>=N#_-6TT)F;I+$ZLV9[HQFS3=QZ8B2_@#;<38R1OE;@5:VES(_IQU M6/."*'JH'#>G@22GAC3+%7TZ1WO@A(]F:1"2*@O).NL(B,U;$ANH M`=2@QFHPB\_U[-;N[M17N;5T]WU6#%Z^CL]%&&\7L+3W6LNM'?M@82RGQ?2$ M%&EB7+;#4V:QL5;Y&2]&*M;F%+OTIZ0"XU3&?(V2!1?0S&RS)3ZH0.:4I5!3 M[KQ*L<]S.C:691=\W1=?ZF!P%#+U M*S_1,D@ M!U26G-8%6(4LVBWQW6VLC!WIU#4SDL99BD2:M)E&*X,@,4[;J3J-PRS$?-Z, MTZ49N!:*X9%(\UC]'J:(3DUTJ-R)/*V!NBMN#`,2L<+2OM*6`SOE#(V?1)QD MI'B!LM:'IPN34H,!Y[IT._&FM7FJS$1;-@WU[:I3^U-!KJQB2]V[LST:N1CR M725F^](MR&7*TRUQ'-G$!:54CRP1)T[U7`BY:'6_1BY/=Y,>D=LJXV]T=!.B MFA3=6LVW`"XCO=?2>",*>IV7+C67C4R2#T=D#IE3%A^K(2D,6TM0Y3&/)7'' MR<-1MB6^'VEJMFC2Q]+D9'+"S("7R>9NSC)S_6C6;-XG?#?6<7_0_9O! MA7,4I@\/W8#6/.GSK9S+S%:_=+I963OKC:[DD30\ZH$N=I]U"T/VFS4PDA/V M#A&IH5M#LG6@9'^>`MQ;"V<5\AY+*8T;>.1K2O*"T,4+LYFYI<@COD9=.<$) M%9EKHN8I2R$XR6P7&5XARXWH,5M7&3)MJ*,\4TN+L469$),0S=/:%+=^1=.4 MG-2%#:6^>"OXW4PMLN]$NIQ?$B_N$W8S*2945'+FED/)\=K"KJ7^W9198DTID0^S1!)!-O#` M#?/^VON-<,^YV5QQZ!RV$/M0DZ-F/D,MC307=+>\+-]T5=.>2'ECL-J5PRQW M-FD@6X`\AVX6E"#R3BM\(Q@MW3?=_F+]\4;E?J6?@$]1W4#?-)3\+9][QOO] M<;R"\[]*V1X.BO._2MK\=WGN^7'(LHYG@.SO'Q++9W\??>HE+CC*:QQ'Z4@6 MQX#46^Z2E>(A7AP*XE`0]*Y6]`YG@C@3A(Y`1W`FB#-!J`'4X&W48/:XH+]W M%E$%;Y4'6K#\_;XGZPU5K(R[+SLJ[/)/*J=H@R=C+N"BA(F*1:0L'RF51V"4 MH_)(9P=FV8BRRHSUHOAN7U&4Y:,HXV[P3@5DP6$W9U\G6SCI+)*.!_471LW` M>2S=.9@_^!L\-4%_$%64#69G;;[+XE2IA,+)X$"D2<:)%8V?$S<^H2"QX?`I M4/=C$`IU-(5/(?_]<`B4P,]/IA;.%A+CQ3.)>!PL6&[JJ=-.G]TE_K"%KI8B M.6/CA\[$2O2EH=GQ08"Z"\CR0U6V2I?([>20S_U"=N/9P;$+\EB=RX"+1257 MBQ).>6OFTTMM,S&FI,ZIO3^S"'GLL1HFF7;!8G\ZEUZW*NY([G:D@]'3Z^'' M?^CZ]*;W@R('9.'CRWGL17XI'(WDK9O$F#/FIU<;P@_A7T7AQ\,@>!@$#X/@ M81`\#(*'0?`P"!X&>?IAD&X+#X/@K!T/@U3)]G!0/`Q229OC)7AX"1Y>@H>7 MX.$E>'@)WJ\E[>5UO`2O$N1\#L[7@9OC\8FU>0D>O@2#M!+U32 MYN`>X![@'N`>X![@'N`>X![@'N`>->,>P!S((H$Y*F%[."@P1R5M#LP!S`', M`-._,H47BBW]F\`P*],X8UR>*,< MA`2O$D',7)&8&6H`-:BQ&N#%0GBQ$%XLA!<+X<5">+$07BQ4NQ<+_4J\Z_=I M;94H+'[G`U@6^=/JYT^@LJ"RT!'H"*@LJ"S4`&J`W_G`[WS@=S[P.Q\0?@@_ MCN-P'(?C.!S'X3@.QW$XCEO1X[C%&L^_]N&H>=8([XOL"```5$P``%@`<`&-V+V-0=7@+``$$)0X```0Y`0``S5A=;]HP%'V?M/_@9<_Y@NZ!"E:Q M=I4JM66BFMJWR3BWX-:QV;7#Q[^O'9)L=`VDFMH`#TG(\3V''$0>`$S.E)0@!*S)Q17Y@8J!U@K)41"Y+\FT+4G.LP=N=$8NI+&75W>L!FDU*\([-\@I(]*P!CN MB=O^'%]L%7B@[%$K&3"5ANY\Z$HDF8"AE!D5YYE,1G-`:JQ?WU=SD!KT:8:< MRK.UI"EG8ZX?A\F"2F>?/YQ.T3K-%^!&6M5._+%9SV'@:9[.!92_S1#N!QY; M:!/[G2CN1+TX"E8Z^?Q?`I[SAQL'&!4L$[:&DI>6?$L6K`S(!"JQSH46+.+& MT4;V$W>)3TH.N[NA(0Y-*B)2,EG`AHP4;,31D8K/%:@8\R*;66%=$8IM.6&/ MJ5&XG5!A1#Z#-;!@JA8A8N@BL]L\.C^*_6ZD6EG6:N!9_##F_K8:TXO-O>>K$M MF7S&M4$^R7)O9'(#N.`,XLXDWFEZ\V$'&$)S\44HG19#&>$-3[F@>*WDJV+9 M-_#`@]DGOXBF^\[1C,P,<&^_KT4=H.FU6@N'C][9X5.5SI6T'3)NYG4#?"NN M[U'OK&\@O:5EH5+6>64(]?B##Z%>>DO+0*6L^\H0ZO$''T*]])8:_I#]SCA" MXAYPW!ID;QCV!M%PS`$N!@V5%UE\>>+V-0=7@+ M``$$)0X```0Y`0``[5U;4]S(DG[?B/T/.CXONQ&+06`;(1:#E\8S M9V)C8T)T%Z"Q6F(D-8:8./]]JZ2N;K54-S5T51:=\^"Q(4OUI5297]TR\V]_ M?QPGP0/)BSA+/[T)WVZ]"4@ZS$9Q>OOIS:38B(IA'+_Y^W_^Z[_\[2\;&_\X MO#P+1MEP,B9I&0QS$I5D%%P_!9>7P7&6IB1)R%,03`K:/&#"1TDV&07'Y"9. MXY)V$9S%Z??KJ"#!?Y&4Y%&9Y6\W-MC3$_J+CPG_+465%A\?V;\_O;DKR_N/ MFYL_?OQX^V/G;9;?;H;[^_N;U6_?<-$B%@EN;VV%F__X)N=38YD]GSZVU$Y:]`4?K]9_Y*+=D!+GUS$'XL*V%DVC,KJ M"VB;!5()]J\-+K;!?K01;F_LA&\?B]$;^HJ#H'[)>9:02W(35._O8_ET3SZ] M*>+Q?<(@53^[R\G-IS?#AZ(,Z7/"[:W]<(L]Y:_'TT_/_Q^EHY.TC,NGT_0F MR\>5#F\"UL&WR],%97Z/AM^++'T[S,:;[/>;9H_:?%GCAXA^@5MR<'N;DZ*('\CG23IZAMZF'6ZT>WRAE\#L M?31)R.`NRLE=EHQ(_IF0XH4U[]W+JM4]2--)E+!'7]PS[TK=\,GC/4F+E:F^ M5(^K?@U3!">/$6MVE4=I<9\5+S[PE^_.[@LXSR[)B(SOF4NU_#+Z=FW'0*ZR M,DIJ5V5L%X=1?D3-O%S*/LPZW)#U^-(O@<[WF'X=:"L?',_J>55CH\M?QZ2, MXL0>7QKWM[)7$!?#)"LF.6F#.H[*Z*2>PQ3/GB`]MY>FME$^-%58,F/F\W8V M57Y?O88[^HA\.+DF&Z.88BFJ*>BTHZ9VLZ?$:;E)13>G,IO"!ZP:]:RKC5$V MCN*>D+NM+>(E-]$D*9<&S)NO'''U9C;&9'Q-\IYH%YNN&FF4)/WP50VFJ.@" M/_B)C^#FHOW?#I+DWZME.L<^FOV2+>@7\)/'DJ0C,N(:L&Y>8BDX[2,NV>.V MJO^"C8"W:?Z5M@_J!P3-)U3PN0))-EQ`G;`5>)8+7WOU\@HR?'N;/6SF^29S MG?3_E0O=V`JG2^R_YOEO7_.LN"?#W!=5'F MT;#L`A/)+&*;?_*#?!$E'4O\@=-A93CNZC8W>3:68ICVDXG?7I;3)=>G-R&5 MJPSA(^,7,OKTILPG9/[#+"WIJ)P2#+4P(T_2.Y'&U;130 MP<1VL$AP6I)Q\3$(\OQC%S5:BJTQN32V$8EKCA=DMN8?;*T/(_&(I!B,:L8C^@[RJ/DE)K@ MXW^3)RG(CIPEE`?T(X[8A_R<1+<"=*W?VT9U3(IA'M\W78X(W(*8)8QT-/)S0WE6;K,U(!LR=F8S60^F_$!IN"W88,7T\X4^XX/V#ML-`7_#C;X%EE- M0;_W!/0"B4VQ?X"-O<5Q4]"[L$&+N6^*?<\/["U*G(+?APM>P)F<7LF. MTWI;F<7=*L'I7/6CW^8OYXI^QD/:^'L+A$(.*O+O:87'E2\(OE2^H`C0S%9K9LX'],J1'T\O M)4B!'B_<6E@1PW7N2#2MK,>+;IL=!X]>/4!7?$-0NOFP M^.L7W>5GWW?G_?O='>$\1B;D=O=#\AT7+ZY8GJK(#R5DW[=Q'M%YO[A!X[$; M@LG>AJBJV/*C)"H*R8I7*@F8RY6XVQ?:D-,]-*:7&K:KP3GO4[9%TY5X298_ MJBY"[.WOO5.P?%?([3)8\VVG=MU]<5#V)@SPRUY\SYUC*-?AT#MY0/6O_J[< M^W6^*XSB^O?Z2KD46%?"*JZO>N;F41_S37GHXN MVF+V$1X^_4JBW!!G2]@^VAY4IVCAZBU+W;-2V#[:7^+RKI$C4N.B^[1U,&(: MV2Z7&#V:UF[UZ36J%`W=:M%O?*E:VM>CQT1`T<(^[J,D8_G@C5%WY:V9,E<79%5_?9`Y'3E%S2"4[%>U7)6EGEE-2)D=LGZ:OL"-A$9>*A5;*V]J24 MNU%6WQSKT.2MR>1L833QE#(Y6QCU7E$L90,?SSQ]D(X:EU\K!I0.1I,VEF_A MFPQ5C;C-MVT"5R5K$ZMV&%C]YKQ3W>Q.)F<3HXEO4LG:Q*KW47))R[:N=DY0 M/%+5>4^W)&WC`GL/R):1?HGR[Z2LTJ+U`&W6RL6;-O$3)FU<8-?[#7T+J!E+ MQ*?`SB\UF^#N'A+#3]JH/CJ&G[A1=YP,/WNCX+P9?O9&]2DT_`R.BN-I^)D< M]0?6\#,Z*L^QOG,]8!.RV0$XUP4V.4O. MQCEX+WA9?&#.5?""I14'Z%P/V&RM/%7G*L#F[#YGZUPCV`S>[WR=ZP2;UHT/ MVOG:S@M2-SAPY_IXP?&*`WBNAQ<<+SV2YUK`9G?Y43W'#YO@50?X7`/8_-XY MX>>P8=.YZMR?:P";S1`*P&9DLVL57!=O.%EZR8)K`IN8]9JM& MIGW+IFG13?-VH8V!H[-7F2+8.E4MDZ#7.*B9&3!-5U50 MLD1130N?G%,9*])P90L@1_T**U8,,0M+X7@KUG2="R"G? M2T&S"2.$K/,OHM;",'2:E&?98=AWU@@A9[V9KLKI)(2T]4NH`2-AO1EPQ804 M1);ZWEH`24[?R]+%DUH0R>F7U`-(.OIE9IF++C0$F9IGG3;!,;@-$_"@06%4 M#J;9\2+-SCI9TEI>H,9D.F@:>'<14^:`ND&O*+[W+//:632ONIO*3H)91P'O M";JQ`8MRPV0ZWB7366\S[!#QH1K@)B*EY,#4/ MIN;!U#PXQ?.'FZ!N9V#2'IS2@=Z>>)6G49C.Q^@\#-/Y('NO-7MCHA]/$_V@ M,>$Q.J8`PA1`,%,`H7?RC.H[GTF>-T4A:CM!D!8UY!1!4O!HG@[-ARE(WOLY0.B+`*0N-#6*6"01.KR+?[(Y1,K?M$4KU.4!\,_)G%.1HS7JAC,=&2"V;"9G:0Y>KBNL-%7\TL4L\#__)+$ MX^M)7E2,HL)JTL8&]G-2FKQ:B9B[H&+3R;AR*N)\7[Z'(O*)"H1<-:9:F$]; M("2L648KW10&0IX:4[T,YC40\M/T5D<^V8&0GZ:W.O(9$(04-,:>6J.$TP0T MIDH8SI@@I*8Q54F!WVU6&E,%3*9:(-+5F"HDF8QU4M5`#+M=[\U`#%["-"IH M:N[WW=H_%]0J[R*"VJ M;-K/LK1WBY8V[2.8=A+\.>_FG]#M#%@`$^9C\2X?R]I:F/.QO':[&9B*!>T/ M.L-A%A;OLK"@!>$F(29@P00LF(`%$[#@Q`XZ+4'=NL#<*SB1@[H5\2I/HC#M MBM%9&*9=05\[&C"N>9EQ!.UKOXW%,MH+)5D`F6T''Y`_!+WXK>6X)F9SM M#"MJO)#3JXB1HS6ZL<:7'?F6"P.Y@8OBHY^&C:'P@ MAOG:;7I@9"F:IL>\B$&GG@>=HG'A-B3&HV(\*L:C8CPJ3@=?"V-!W2;!4%6< M_@$TIK4\)L,H5J.#.HQB1:9'IG=]4@J*]U]1@"N:&![[8^PKQK[Z%/N*/LO3 M:8'\,YJ&"HK;N`V75>GA3^BL2`LT;'"&;<>$;&/O&X6K;NM6%[/H7%$+`+BU M4;NB%@!P:Z-Y12W`^E[EG0P,7493PN--C&KV M.JJYKO]\E951%]$%:9KKH)IOWTM[#@?WF7__>J MS^6<+R1!7>!Y%?'+ZVUFS@?TVNV,8*0R&J$77(,4SK0VQ.O\O0*(XJ-SL\PHAC9>ZW9&V.'/8T=1F/" M8W2,$L8H89A1PNB=/*-Z_@JJ+N7QBQ(QVU&_2K20`WV%P-$<'9KC2P[\%9TQ M5*^U?I]'476747"N(!*RCDX1-2R3LXWQE)IF]7J.HU(#LR5J&VFXOR^(2>U* M.,`EB*GN2CC`M:W%U3G&L8)+$,O=E7"`ZYT65R?ZT@HN00QY5\(!K@]:7!^< MX-K5XMIU@FM/BVO/":Y]+:Y]^[BVZ91*C:N6<(!+X^]K"0>X-/Z^EG"`2^/O M:PD'N#3^OI9P@$OC[VL)![@T_KZ6<(!+X^]K"0>X-/Z^EG"`2^/O:PG[N$0Y M9[H2#G!I_7WHQ-^'6G\?.O'WH=;?AT[\?:CU]Z$3?Q]J_7WHQ-^'6G\?.O'W MH=;?AT[\?:CU]Z$3?Q]J_7WHQ-]O:_W]MM.<8B;;ZL*-1N>W:98!W\UWYC0Q M6%_\K=U)"$G`^JI0[U]"R/.U!/*PF\K+$^3;,^0=-@..?)[LKL-WP)&_FR'O M,")PY/-,?!W.!([\PYR8O*+5>KN60_>*5.L=70[=*SZM-WTY=*]XM-X7YM"] M(M)ZZYA#]XI)Z]UE#MTK*JTWH#ETK[BTWJ/FT+TBTWH;FT/WBDWKG6Z^3/** M3>O-<`[=*S:M]\LY=*_8M-Y2Y]`]8]-&FN9MS]@T;*0Y]XQ-PSF;;GO&IN&< M3;<]8]-PSJ;;GK%I.&?3;<_8-)RSZ8YG;!K.V73',S8-YVRZXQF;AG,VW?&, M3;?G;+IC'$[G(E_M>M^2QRQ^6-\`3Z'Z(+LMJZN[$UN?3]5!@&7XPX(%_A4L0,L#-L;7 M;O<#:QB@7?K*B%C6P+^R!FA9N`F)E0ZPT@%6.L!*!S@1?&5T!75K!(L?X,0/ MFB6MY`GFE-.1Y+)/A:(@'M"X_WL6K""UPP<+[/L295$]!A M>3\A6/B&]0PTM%0B#)%I^E2-M#0QMAIM#X8UHOP?DS**DV]I]8V>:75[`;O@4?=`_\J:;]:]!'4WP9^SCL";&K!+Q!A? M[4U\-1H9@.&\=ILA&$J-)N@!SV'4M#=1TVA$N*V(`=(8((T!TA@@C=,[OY@) MZC8&QD+C=`[PML2K/*["L&>C`S,,>T;F7F/FQ@AGSR*#GM#0W)/9>EY$P/@FM#`\&\)0)C09F*2T M-MNO&+6TXD/#N&#;-91+V\9V')71=+>F./IV>7IP_O,!_?/P[&1P'OS)'U]96=5%P/L(ZDZ"NI?7O&OH?)D'ZKC0[^BD M-3(FY\-V[78G,`II34T-)F]AM)$_T49H+.N\F8=111A5I'9?T&[P8%31:XLJ M0@8"OLV`T4,X/0.P;?`J3X)>)DKHPYY!E-!<:"6!2OLF@4K[JX2PMVL`82ZT M$@@F'V)OI1]BS^1#[*WT0^QO&4"8"ZT$0F@"(5P=A-V]_0]:"$VAE4#06T13 M:"4?8MOD0VRO%())#.6^)(;RA1RTB5%^6*E1[IH8Y>Y*C7+7Q"AW5VB4].DF MPW%WI*CEB?TMOE$VAE7"$WC4U MA5;R(4S&PIYD+&"0^\L$N<^7!QZ!GB\HG-<[,@<]7X(XKVW4`W1[>+BK8]0# M='MXN*M59`YZOC!J%R2"##IL@=X%#[JY^)J"WO,!=-M[[(,'W5S@<7+IU&:$ MB+J3]\4'3OS0=GJA#Z2XV_9ZH0^LN-MV>Z$/M+C;L48?>+&;A<_7,/"YL;DCP%'[P(U[[7&];7HC#Z]+X'4) M3-GF9\HV-)EUBPW$U&R8F@U6:C;T09!I&U.PO9H4;&AH(%*MF=V9O"2W["I[ ME);GT;CM#.1B=F?R]-LJ_53]^Q<]&)_)'X@46%?"*JZO>3R.\B=%8D&%J%6D`T)I862(521L`^W)XSV= M6,J_=OOW%C&=1WD>L7>C>'\*46LKK;LLH7.$SX041]%]V=@1:*VW!'(N,&;) M9)P*Z$(M:@/IE^@Q'D_&1Y/Q)*F^9A5L=D1!W9*+!Y)?W-S0>5)Z2^UZ*$#? MLSD(CDCA]($5)1L?Q0SRBZQD6A[H0PJE7[1E/M#(?)",R MKCB!^EW6]_P'@IFA2M@Z6@T^6S,&ZD+26V+P]A2BEI$JL5FUMX/A,)NDY?25 M'!0%*06;VDIA)V@-,+J88TE=9 MVE<375L;NAQE=/:;T@$15FZ`#V&5"@9-K"+?[H]PP2S83.+^TY*N*ZPT5?S2Q2S50F=LL;CZTE>5(RB MPFK2Q@;V5KJ(5:.8K*\O,F2.+N:Y&E& MT4AW>^623G`J-GY5LDZP7HI/N<1B%KW9YRPKTZPDA7X7721JT^_R_:=ZG\8` ML**%3=R7;,U^<=-8O9M@5[>RB/\P)]'W^RQ.2W9*S];-"]&YYS@NV)4O^=?0M+)J`^0^ M)P5]B8=9>?=6$;B3:"C%K91,__7\2U:1\<4-7ACD93G*V=Z_:;>K5 MV/I*X9S\8$/B,*J.64Z*,AY3\M$M&Z2M'*\A]&KT:FQU/=%\OS]%%%691UE. M)U91_C2#2$AZF@Z32>.ZEF#9T?]1=KU`4=+W.[K*+LE-0H;E$;4#HO#&BA8V M<9]GY5%&^TVF4)@I'T_(5=8>4W)%>CS"*J]$X_M$>[VC+68?X>'3KR22+TR4 MPO;1]KB:HFCAZBU+M_^5PO;1LNZW0AU,+N4(WXX1ODXPMC5\[XWP=0*8;>%C MB0ST^+KI#JQ8>38_'5["XC6MW>K3RQ,H&KK5PLQ#B%H`P*WU'*(6`'!K/8JH MA7O<>D\C:F$?=X\-.T4+^[B/DJR@TS%CU%UY*S628Q&=O*UX"V6DA=6OS3HT^=(R.5L833R13,X61KW7 M$4O9PG>6%>1+EI(G,;#&KZV-O"P=L5/*(KZ)R6A01N5$L*TAE[2%LWHM7Z+\ M.RF;]887(7:$[+W%\C1E\8RC8W)/!Q=]ZA/]01F7$\FM79-&UJQ&-N]?^*4U M-(IK?NW?V\(D1F*G_T.ZOKJ+\O(@'35*&U4!R5(2,VECY5Q\WKD)Q6G$+2-N M%/H\39))444KFQY>Z\ZM^F[>J8GC5LG: MQ#K]B-/#PRK,ZRR+1H+AJV]AY80[32=14KM_Z2Q,*&0=G6)6)I.SC?&4FG+U M>L0Y)A2BMI&&^_N"_<>NA`-<@OWSKH0#7-M:7-M.<`GV[;L2#G"]T^+J)%>V M@DMP7M"5<(#K@Q97)T&R%5R[6ER=%,A6<.UI<762'%O!M:_%U4ECO'IUA`-<&G]?2SC`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`&^%J$NDHJ,0N:A#I,+#2KFH(Z2#N.*+Z<5-(\3M)HZ0ZRZF:EO8P-T(GAN0 M!T)[?OHU)LE(ZGJU#9RB5CAADS8NL4M"133B+A&;@W6&DZX93OZ8Q`]10F>6 MYJ!%S6QH<'47Y^63U@8E8@X0*NQ-+FD?I\2VA$+VT>F`6<9D8C-*X46T+UP$ MNRI]O3%>*"IN6-M77@S54@'O9V#/N]52VR6[X8%65%B=@N_EU"KISYPLB M:-%>ZQ1_YVX8*/RRPK"K)T'XXAJV7`4OZ+U96H0#ATWEPOJW'#ILHI;7Q>7X M8;.RLE@N5P$Z&\N*Z'+\L%G6O)@NUP<`[V-S=T>"R>=[[#C9?*^H(JRPQ M5PDVL9N5*.8W76!3?*\ZQ5PE+XA_F?+$7$$_)@;R3!#$U8VY"I[,!:35CKD>7LP#Q"60N0I>T'^K/#+'#IOGQ:63^0U0 MV+PN+JO,L7M!X*V2RQR[%]QL6':9Z^0%3^OK+W-U?&)G43UFKH=/1"VJS\SU M\(JM!?6:N1X^L;6H?C/7PR?*5NR??O")OKNY)'@@!&PB[Y2`YK!A<[BJ,#37 M`#:3ZTI%BP M>=FPM#=7!C8SFY7YYKK`INQ.'7`.&S9GJZJ#%Z9)Y=!A ML[%;D=N0*P^;E;FYSCALW'W=KELV0JL$FX6]Q\!APVX7:KG\^` MPV;7;GGT&7#8_-JMGSX##IM6NP769\#]X=&Z`OL,N#\L6I=HGP'WAT#K&NXS MX/X09UWD?0;<'^:LJ\#/LGCYPYQUF?@9<'^8LZXC/P/N#W/6A>9GP/UASKH2 M_0RX/\Q9EZJ?`?>'.>M:]C/@_C!G7>Q^!MP?YJ3`&\P)/(U7JZQS@SF!I_)J M`6\P)_`47BW@#>8$GLBK!;S!G,#3=[6`-Y@3>/JN%O`&(,Y@2?I:@%O,"?P;%R+P+<;S`D\Z18_9U'I2C0/"3KK(J%]EQIFJL-EWKFIUUX,7H#S/RBK;,AF=IO-2&PVM M8%,SN_QQE;'#I5IL6K-OAAXV/_-OTM9BX;`L!)Z;2Z9$0P'8G#TMX2RN;S_3 M`39]SVY+"'5IC2?8A*Y6I:$&;'H_RWYH!Q7PC%S\2PA561Q3P--S*35I:`&; MPG47:T/@N;G:^-D-(_GUHA!X=JZV-HT+G$=55JC&W!!XFJX*]'EV3$:3(8-$ M)XL*^A$&Q^;RMTD9)J)7)Q\#\D#267'Y M-D\`S^PEU4-`%L"S>LE460Q]#('G]))IT5``-F<+%*"KK9,_)O%#E-!Y>UL; MV`1^=1?GY9/B`BU+!IZW:Q%[`S9LBI[!5EGM/'/7WS9; M*IS1?]:_^#;\76?IVF(TW*\U9*0:ZYISD9*[E,2FC.*%SB^@DJ>KB%$??+D\/ MSG\^H'\>GIT,3BY/3P97E]\&5[,7$9>LIRWZ7[@?,!WX8^D_V),WZT<'];,# M]O#@3_[X?U*ANHN`]Q'4G01U+PN?GJZ+%Y2F_X[*;/;9[G)RL_C%"S)\>YL] M;(Y(O,FN2+*_;+"_;&R%&SOAV\=B]%?ZH]^.L^&$X6ELH?`?'3S&!>\@88G0C\H\ M;P_*Q:VM+R1BR`5&I)![(=/IB5%H04I)AZ:D?'7=) M:$8J:8-HYGW*"*8KX9A8-&^6)_SMP.;EJ'1V,_TY^^,Z*@C]R?\#4$L#!!0` M```(`+ED.D'?[KE#(2@``"IN`@`6`!P`8W9S=#$M,C`Q,C`Y,3!?;&%B+GAM M;%54"0`#7B]C4%XO8U!U>`L``00E#@``!#D!``#MG6U3W$J2[]]OQ/T.=;UO M9B/@&`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`?A>UQB((Q"GP=I[+'`^)@4]CGF22XFNT[,HI-AF+A(3&WL^_Q_Z(D2A9S.-!8E+2!BZ M+L+U!E)N(6R3.QXDI]\%0A%T+").64::\ZQTL8CN.P)V]HTE0.@"1OEVT^'V M3\+_=B&W\%QKF:4119?WG.:S+'[D=0&9RBV3R6(+'`)KWO30D+ZQV2D!@@`( M0)`$'8N'FRSBU:WKE^5MNN@(V-DWE@"A"QCIVTV'ZS])];<+L87G6JLLC2CV M%.",%R<94HH90-MDZ@1`Y!!V_-_R4`__-YN=#_Y%$>B/_651QP;BX]T=G17Q M$U40T;&9BH30)2P3;1`0W=G=/+N_#Z=]IN%'>= M"2X^75%]U_:E_RFY2[-EE776FTZ?XUR2!*364].!IANPB4'FK$X1W_G?_^$R M-6@"TD\2!M)@LW2>+J.X.X'H[IQ*2ML)+!CKMAL9PR4"[3/M*]Z/*,[]@&8E M6:R_7VB4KS(J2!`RH]'W!Z53H/N$V$?8V$[6.QPF!'4D&K<0K0*6Z!!F`;D9 M'"$8F4'J)?Q`V0Y*;J)GZB1+Z,Y?18:ES'%Z5]"L#-!E5B[5UR>G_/NI[SRO+%*IF_#B5X_-)L3K/?WNSS)>Y@NAP,T66S<#Y:/Q`= M(,S!8&%(=>0KT>=@J\]!6Q_DZO_U0Y31LT64YZ)ZC]1L^A,!L6/H9P,=+V'Y M-RDWN*SV:*(@>F0@5P"%D-J=8(1M1>ZV&]Q>D(27;:M;1X(48:(0G<#+T1 M[[R>&_=P`:$&5KUVD096`C__HVEIZZZ#4L0:!1I+^\_<]JO8]8^?[NL<++','HWFL]W&YQ M*[KLM&O-52'&E?Q;%B^C[.6&/A*6A&\*M]#NF#SG0M*\[-(]'*8S&A2 MQ4_J%+#NU_<1-K83OH.L]U2XN'FLI@Q'IRJHE,$&(N67262I16,+!(RX"RC< M=%SU\?E>6OC`C3@J4GSDVN`,8A\ISVW)_3K725*-W&ST\%7C&&CL*O,2;O>0 MS2X/4HXN*(U1JX$@.*OXDF05+7CYL-<%90H:<-SHE7U#NP:TQL_8;5B95L57 M`8`.D];@V#56`(Y1%G.D?9&F19(6S+UZI"VRFSC2EKL&'6D+W&Q'VMM]OHRT MY3'IC;35BF`RDY_3.YIE='[&;L?W6G04YA,)TG8$%"2YMW";E38F9&WC"U?: M2/7P,E(-E;(KI@:]O/OX/'O@_RH'?!K2U(=,I)JE=(2,E&AU*Q4C@2):J?,5#L>5*\, M(J3.5[9J6&W?O\?%PQ6=TV7I7%G$&G(@#&:DMG=9R1H> M/QF4IOK:N*>F=4>&WE\UAP+=:XTZB'+?57ONL_HU;9+J[2W9**#2V[.QZ);A M-;]M*XZ"1];:[5SN5`/J#OGPXNF=7AM($TI=C@":_1AP_U<=!H^HO7N_PJLN MFWISW]='S@1*I_=\T\=8"G,8"BT]U))[Z\UZO'O&I8V4C#9W3[S6'3A;I/SW MS\P8ZQO#$";K!`9?/5\]NM86GK$EBY&,+)56..^NIUEQER[B]&:5)>D3E521 MY6:CWUW7.`9Z=UWF)=SN(9M=;NO&NG@TWF(WT,(.*[+\HS($XP4I[RC\")EQ MG&[T85&`8W%I=,%FL_3^19Q=>GM'KVT5NP%:S=II/-QL<)LX).?<6*LJCRZJ MUMJ2E\IP*@'8Y2R%GYH+?\I4^K#T>7%0@N+O#W6B]KNW]!6 MOIMM*Q5P7]HT(#.:HC+VY2_Q46GOSV6O#D6;"4>7N[9@(C.:@@=V<43BH\+# MGSJ(.A1M/!S4/+A;3:5#;#(%#=RJAM!#A84O!0Q5$-I(6"]6?(@RO@BX.$WF MC0^TE_5>\:C!Y("QL)AW!@8=`W\ALRD7?!?E5\^;/\I0VKD=E9@'K,9LF(#8 MO]:@']+>BVS=>#;^E(L;9$93I<=;;!QJYTVJPRGPH$]?5;X:4#BSSQ:'Y<^-P[FTQO7FCFU MW&PJ-[AS:ZF7!C.^3+)U$>GS8G]E@-$,&WQ:;64N+9U`]Z?,ZUV.IS7J6;(' M4^/2[Y#YL?0`*'`LSI1E_@0X;:U\`&K@9-E`,BN8F=*%`)4EEB0(.1P6:P,A M)\8>*%^B[`3,Y`"HE(4]63/P)[@/;JU\2&8F\[9ADEG!3#./TYM#(88[K]-Z$^#ERSS/ M-%)RSJS/^SJ?MCR]S8LLFA4=$*160)\E[;H%6K4G<=+[%.FO'GR#M!L"Z==' M1<&W\H'C=+%:)E^C95=1A1W49XY[KE$`:;@1?.RXW.G1MXY[,9%_[EBH"-*8 M_#E>KI9GJ^5J4AANM# M7(=K&[T_+QS2G\\OD&P/F M(;Y:<+^G1=9?+OBGUS)-71. M:`YND#'N1+#&&P-[(QYZL"%'W0K9-E.N_F\UY-55,5D3U4!D/%\X[S!M/TMT M0;%(["QK>FV%[A(.)TF:Z2HOPJ%5W2N1,\#8+5 M>`'*LER&OTA_4@F6T/N(70"?I^C&?YS^OYER\M^?QT\.JG0`1!3B)=]%Q3D% M&MV!(FKCJNQ?A[X'U_)EU/AE#N4=5F$W_HMH&MS&<=_3=-IGM,B%\]1Q983IY\J]Z`S M2Z&C[:1QO5>>(TI[EW-"5:!ZTSV=5':`TF$$"`\R,D)0O(#!``'+JUY$52ZA M!7)4OC%'9@O[N,LSQ.[D;PR\M. MELAI`Z'XL65KR^3Z/_,L6RBGM(3[D6ZDQ7(J1\*?ZG:]8,X@,JH?Z[:Y:"YA M([,E+6]PN6+D*C,;/_)0.X8:@$B\A/6>:HVE=X-5=7B:PQ2]-"CH-)]SG";S M:YH]Q3,:[-\&2I3,#QN+UM".P:!F[#5L6I8/T-:VY$_,>C?XEQ)(%]`-#5P- MX1A1T:&\S*[C9;R(LJ]I,@A+W8$08)IU#AY-C=\VG&E&UM;D3\R>>,2G6?S$ MA)KKB\+H6;I\3!.6L(-R.K&YZTO1-+`?2Z1Q5V!`U+L+:Y-J8K@=U+D`SC@\ M-6>#Q,+%:W\@7G+[R7CIN@*,E]1=C=>^3WCIPB/`RT0L7+P.!N(EMY^,EZXK MP'A)W=5X'?B$ERX\`KQ,Q,(I:1A!!8Z2%8"DV+194&&'^ST(AT7;LMW`I8&?H]BO@H^NZ+Q\G:5Y66Q6GIQFAPP%ACS MSL!:I)"'<9L?]2B6S,,F0LB77P/1/V1#&>%XG=QE6?[U^69S>$WA7]@+E5;\Q M@8&G[1#C"E][Z%_7/^/B@=1O$NV0H+S.W1/4CHF,&PP=+%RZ6T?A:PRW^XOS M0']Q'H!"<8!^<1Z87)P')2TN:W?"H"AQ`1;"UM7)'86O,M[N+\]W^LOS'2@5 M[]`OSW09[VLLSV(.DHG:(=7DR#R9# MVSV?>*FCHN(%6@E+UV?I*'R=`7=Z@7Y-:V*-:I/B`V"0474&XU(6^NM?V%_3 MQF7M03E3%289:CK9+*,VJ.2I/A`>/9NE4*5?#8K^5DE-HFE"J@NU+=RQ-.Z] MJ:IBR>C-'<^@\BHRAX<0OR(K\*9-+[X4"^61,J$/6S7+"<._6BZ$/'ZE!'6] M5V2.!!=J'5C@39L2O*E0RD-E#!VB;"YR@E\59`A]_$H*ZBJSR!R)+M3JL\"; M-BEX4Q>5A\H8.D397"0%O^K6$/IXE10TM6V1.0Y=N#5O@3?]Y,&;8JP\5J;4 M8>KF("OX5BV'$,AR6O@09?Q'+HKRAX$EA7.)S5B0E"YAKGJQBY!M+G_FI*A^ MTME)"5QY]C4FVICCO,V;)*MH<46+59:<1:(/G@LM1K^I*W<']%ZNP$%8;235 M5K+>[+#DK(A"XX5;Y+BC9&^QGW#]S]<4:]MOU3=[('NX)#,"H0+IH9'$1_N: M].`QD#H6$E30-,"_.#UY;#,M[`XOTD_E*;%$<1X5JNNT8P>!B=`U_-7:=M.] M8+=["=_M&AUA2,3T8`N"?NEVO87_-:1P>"T')R?=:DA_-P0H34?P%VS9>F>P MR[>Y)J)YUF(0NA&VH7CWX7E_-Y#BP`_'>ZWW%0\\4%SP)%4581N*[ZL5WP=3 M?-`=8+#B^P+%]SU0?%^K^+YMQ;M/P_N[@10'?MK=:[VO^($'B@L>C*HB;$/Q M0[7BAV"*'Z(J?BA0_-`#Q0^UBA_:5KS[<+N_&TAQX(?7O=;[BK_S0''!H/A[#Q1_KU7\O6W%C]2*'X$I?H2J^)%`\2,/%#_2 M*GYD6_%CM>+'8(H?HRI^+%#\V`/%C[6*']M6_$2M^`F8XB>HBI\(%#_Q0/$3 MK>(G5A5GIZ&JN56[(11O.H)7O&R]HSC?YEKQYEF+%>]&V(;BJII;M1M(<<2: M6]EZ7W'G-;?F64L5MUMS8PY5-;=J-Y#BB#6WLO6^XLYK;LVSEBINM^;&3T.M M.%#-K>D(1?%>S8UO\T!Q3 MM51QNS4WYE!5)V:V[,H:KF5NT&4ARQ MYE:VWE?<>=92Q>W6W)A#5ZSW%`P]J;J+7OU01MJ&XNN86@-7<`M2:6R"HN04>U-P";;V1+/HGC;]2CZMI+0/1`2"D?A>B=I4>+DDTL&\6C`8J:( M+6X^-T]'#LW:#)"8EF,T7"HO8?D?3]!HG;B2BU[0;4$A_-R[P@X0"XP/O,O= M./PTN/;KV-V2MNO\.@IZ=H#TB+N"AHU'7=A^7?]42M/ M(!('10F37");4"F_C*8U!T0*\SMI.F\^?)3+,")*G*3JH-!T%><_*K_GM(CB M1?DM7/Y)R`^L_1\=W77&8TDRZP0,1QI?(=__=EUNJ2S(]]+&R3\"$IH]DZ"O1*9!G_O_*.E2XIN5@E\U]< M("$+20T!7OB'?6E1?S$*V@_K;>1[M=7)E3<\S/+/*4X,^J`E0.R&O=4#+J. M<%+?UHN``3:>CI-[;Q)?-R!]!."#CY7X&NV']38O$I]YF*$3W[9=W,37<&,$ M_2L1`SGMJ2>[QV"SK:XCI+2GFNRF+(I10G/XL&#Q*<=]L.''RWQ"2:[ MQWY,=LW##)[X[$QVC]6370'VKT0.Y-2GGNP>@\VVNHZ04I]BLEL6/%9+?S*? M=M0/'WVTS">8ZQ[[,=,O'5NZ=2T'6$ MD_BV7@0(W$2S(IY%"_\&?]W8]&F`UP$K!3;:#^MM7J1`\S!#I\!MN[@IL.%F M*/^O1!?D9!BHDV$`=A$&5I)A8)(,/1L.=D,C@`%!'+C0.,W@N M#.SDPL`L%_HU+AP@"V8J/#H^>:](ACJCQ%YG.S7:C^LMWF0_8:$&3;[-=K%S'XM-WKB7XD2R`E/]^3:\".2_B)_KA_Y^I#W-(S",^*.EO=YC7[[-C[1G'&;PM&?CL6_+C2GW MKT0/Y(GOOGKBNP]S\?4=(4U\]^7)[U.2%W&QXFVQX?_IHB#OW[E.@/VX",;] MX!J@S7KWNPF0;_,@`0X),_BL=]]"`FRY&<+^*]$$.0D>J)/@`=@%>&`E"1X, M28(>#`/[@1&@`"X"6A8\$&3!`S^RH'&8P;/@@9TL>#`L"[H?"PX2!3<-OED@,/1H#=:`C>^P&//-K;;H)E,._] M6`9C'F;PM]WL+(-YWU\&(R?^E2B!_**;>@G,$=C2BZXCG(1WU%T"(Y#_O0># MO6XT!&_[@$<>[1TWP:*7(S\6O9B'&?P=-SN+7H[ZBU[DQ+\2)9`3GGJ9RQ'8 M^HJN(Z2$UUWF(I#_R(,17C<:`OW!(X^6\`0K6X[\6-EB'F;PA&=G9XX\&`KOD/&9TY?%=3.<> MY#]MH1=>"+3\)WC&<>3',P[S,(/G/SO/.([ZSSB,+X!7(@QR.CQ4I\-#L*OP MT$HZ/#1-A[Y\Y:`;%P$)X!J@9<)#028\]",3&H<9/!,>VLF$A^:9T)./'0S0 M!#D)JA8X-W=/9L'"`N>&ES4(;T___:J"X%N4\<6>[I.>9J4G1LS1DEYO:3/? MYD?2,PXS>-*SL;2YY4;%^BO1`/FS!NI*WS%8O:GK""?)'7\\1ROL>M9<-$U_IBOUY3S/R M@69+-C-@VS.:S)QGPGY$>LO>$:*/]+9'L_VPWN9!)AP29N"W/>IV4=_V:+HQ MH_Z5J('\HIMJ?5]S]^1W?BRL[VMXV2!PD47)#^:0W-#EXX(6:4(NLC1AM\&, M?(FR'[3(G:?`7FP$;_Z`ZX#VPEMOM1_?YD,*'!!F\!?>;*SV:[D9RO\KT05Y M@JRN`AZ#5:2ZCI`FR-TJX,T#)1_2G$/`I@./4?)"OJP61;Q[NGA\B-8\$';7 M9/.#Q>:]IT#S,X%-E.Z7"XWZIFDI\KZ5P=F?2[;I-,_9B)O_U.'EW0W-EG&R24M-Z4>U,):P"=V%20%C.A"R@TAU M%).6M(XC*=]:';E3_C@F2>](XV@7[$Z(C' M8QHGQ7F!1.$G7.\C]4ZRW5O=2)W<0O6AJ3^!/Y^,\9S=L28+4'#*1 M7Z,.@3*K]KCE=&-&*KNR]D(:ENY3J5'H>D@:RXF)87Y%'QD=[#+XD!8/7Z*\ M8,/(9,Y&F?->#=SLD(D8&G4(%$.UQPV&.=F:$6Y'*D,2,1@K4_<<&L6NQZ&Q MGJ@*X9K1A MS2>\37NR/H#3Z@&J`P+:)W:@Y"C@7A8/--MTZ"O]R1/XARBG\\OD8U[$2S;% MZM['S0X9B^J0#L$P:N0Q+*W(QFR',,/R'KY#2EO"4-U:.P1S2/AJ(H=*BH+B MZ:P:P7+G#/V<9>]-ES1$#CIR+)@CN@?#YQ#'X<:X&E]R\_+>7G/K%:TC8EI# M.U)UU/M_ZT+Z2\0Z5&11FLWC),I>MKVC-/F4S!8K-F"6C`9&M#-U;#"ZZ[`C MA>'=J,<-[1Q-V-&D=7B]BS=`-BUX,(X8'?S^J&(2.LB3M+Q@5^/\)KVB=PLZ M*ZI%K)*:E\)\^N1,W1'HB9G$6W-25IF0(B5KH_4*W\(#.'7A$LW%]-*AHO8U M+Q7"AH\5?L/JV??6'"$+F`X:3<=EN\+ M\K])N<$A!<)SKD671A9-XZ]I,J\_(G3-;M>K[LU0;C9%>95C.`B$7BH>VKM( MM<\Q&JJ@M"G1"8(&3(EFM8Z8W^<$K/0LIF`B<0='2-=!!4>5)];+IL[I8YK'K-67QB\0"%.)YHAI6<6H.Y`)1NUPDVL* MLC8CM5WSIQJ<)QZCN'5SD+&2:/R=18\2SK9[IO#4:1Z.FTW#%1_KOURIWSG+ MMLJ"..*IF2Y6R^1KM.PJTMTY2=.>$T!9Z[;7RI8;'%_=_3/N2"R,+)K*`FVG M*0JOXUH]M[*)Q<)?`$VSNY1_76!&/R7EO_CU_VFQ6.7EG#3_OU$61[?Q(BY> M+N^N:+'*>HN\1K8Q>@'UE"X#+;`>U86P<1AI'$<:!Y+&D7P=Q/I8AW!."G=C M)?=42+#QOTSHWVF476:?::X@O&,&`+'0,3BG;2\M%-DNPO?Q=U'X7C]@$X9% MR)-4$FQD3N?\DU3\I]>JB=BG9$Z?Y>A(S`$04G8$'"6QMQ92MR$(!KIB<+AAR@[>XBRC??UPI7K:$'SSVDT[^9#O?E8_DP[`L.>UEO( M+$AI4@.W6:-4FI'2SB%TI@&K@1LB'BIL5S3*T^2:4#9%M2X1#2!IMD6UCI&K-@TMCNC3]BP<&->3+JRP=7:19V3UVJ5^6'9Q_ M2KYE:?[(>MY;]3#PV.D7S8`N0E\?)J[;ET)5@61WZ_5EP.\&ZZ-(G)#Z."^@ M'Q!:$=\#`4!!F5>S;E+^-92J/Y^;Y[LF2F(S%DVE2Q@$Q2["LO)8I-6G;JH] M.Z3_G_8_6J$VG)C!5!V#SE=!3,ST)\3EW]%4;D_CT MDXY.(ZLL&7($SY`=?G3L^$2-.3'HM/PEOG^@>?'O*^:<9HL7^7U):3F6&0/W M,-BH'(7KG62[U_WMRB`P-3VVI1GVM4UVM,F''M7^PE>OA/S3FZBW`7&/%`,+ MU0%3;PWZSL#>)!3^%!>]ZT&&/DK]&X>9:@Y(&T09%F$VZ9*3Y1]30WE"9^ES M^M-L-*(R',N0WCD,/PH_8;7/IY&(/BHU/79501F&*-VY&X7`J.!H#"+LD&(( MHK"?>G_0=@7V%B%W)[_270\_M"'JWRV,!+./V!"\D-"RB)44*>]@&@B2S54K M-]'M@O(GR;HE`X;'`*Q;T7<)?.&*PF5KY4II5ZTD$*PB<+QF11\WX:(5,S6M M<-A8DWI6?I>UNU#`Y``H`N6=P<%/X$_`7FL1\MK.!^[DT9)#IU8/A;C2V=?T MG,Y7,[X.^B+-^#=/-A])N8F>>U_5,3MD+'5#.@3#G9''L`+L:TJV=N5SUK;L?`AD4.GE6U$MJ!<=R9>&"/D5)<9.R*^*FX11 MSJ>!P%;P;'PMG^SZ! M[`,0]=KJU_&*@4T&Y$D!^[K`^<6#)S8WN:>G2;)B4Y2R<"W^K)7* M1@VC53,V0#>[E,G2D\D!X*PA)2H#?TKBW'\>T#QB!LBYSVVB#^%H;*%90_@4 MCMJ5FK#2QB>R)%_",5;)*D^&*,%39`<@-3L^46,.C`M6;J+GC_]8Q4_1@LTF M#<$1'0-(D;Q+:$@)7,KXXE7(VM8KW.2!4[*GEA,%Q)N'."M>U,-ZBG"MBX@4%7L# MZ;9CT?!9:`'#",)06>2@3X:S0;'B_&4PV!D`MWTJ$8!2'U/XON;NU=8);4]C M[7!5:3E9?>RAJ`L``00E#@``!#D!``#MG6MOXSB6AK\OL/_! M6_MU4XGL)'8&W3O(K=#!I)*LG>J>P6+14&PF49BA1?'E(ZH>_OBS]P3.+8B\,?OS@?-S[,&#!/%QXP<./ M'U;QCAO//>_#7__[W__MA__8V?G[R?1RL`CGJR4+DL$\8F["%H.[U\%T.C@+ M@X#Y/GL=7'P>W$3AG,5Q&`WV/^Z)_P]6,?_)P:?5;UX2KP870<++3-P'-OC[ M+VZPV-D1)?A>\/7.C=F`BPKB'S\\)LG37W9WOWW[]O'E+O(_AM'#[G!O;[0K M`S]DD7\11ST@W@MX6<&\B!<_4(G_-DJCG:.CH]WT:!X:>[I`_K/.[M\_7\[F MCVSI[N0%\,L8#'Z(0I]-V?U`_/O+]*+R`[^Y\Z]Q&'R!>6G(*,V?SC0_B\&T69Y*D7?YVR9!4%9RQQ/?_,3=QF MB89?%)KYOU/M.WO.SLA)U>O+:%`+`BY^<;9:+MWH]4O@NW?,9XO35>2YP=EK MX"Z]N0@[7CR[@;@]=XX?'B)^)WO/[-,J6+RI'KZG?+7X[[E^<8\N5CZ;/;H1 M>PS]!8L^,1:_[T5O7.@VK_0X"%:N+W[G^HE%_$8/'LY?GE@08UWU=PG8)H%U M:>8$5*>PE8<&"Y?>>N-8M=J^] M1/S<7OJ_P)(D@7D&LJU^]Q5-7G1G/Y4_R/ MMS+W]BK@M000P^I0>@:Z3X2TF->JPM1LY]\]T%! MJ1RCAU`1N$9W@(WNC,7SR'LJOZ)5@I40PB`K.M<\#Y%XBK2!QP)0+0:0A=H M5>>:YP3UW3UE#YX0&"17[E+EJ0^AQU.O<\USM"6>+8V6YK94#](#J"K,>^8E M=C_LJ@[[K;Y[\QS1VF?O2Y^=CY#P_Q`G[F9G#K)3!^+

]RI.2/=S;;;[.W MMMU\8[NYK>?7_@NWF\%V;3;1D=3&JZ3C54CL:^3L+ MEZZG#@FH![M@V?)V*+.5_2W*RF(&+WJ$GFED=0-^2I MO4/-89TP!6\"/5KE9D6!>WR?L.C6?6'Q=7`F.CC>W4K@B8^#Q]8 MI+!N?19-]*WE8YICHZC-:J"GY!7B6'F$2_;@^ED'7]-(UXX2:YUK^CHQ>=K6 MN'JH"VZ&JBTM6QB7HY/('R<`"+/-K7!G0: M];J`M,N:V-9D"+`FY%(1D+LIB!YEDU+9L<:9$%$,F(!8@3AZ9`&Q$B[*#?O9 MC;ZR))VBVI9SNU/H(6^G6]+?UERTEEWPGU@ZQ]#8`\^/T^.J$;GE^6<@P^N[ MW[*IA'J$]NNH/[Q5P_2`ZDJE.Q0,IOKPJ_<2-C+YR:KH(LC2U0G5L)% MZ;BJ&T^XNF4DIB!Z6$U*)5.48?;Z9A9:JN8P>ES-6B79;:W2@6U6&"7WH>^% MMUQG^,PB?8-J#J-'UJQ5YH!QYCJI,HP.%@CL`=UZ.SO"?(E]"L,D"!,6-[S$ M=''TZ`)B9;.`8J]DHW2VSF.)\:"'1L9`.%G4@&9)',6/23E3-WA@U_?G+_-' M\:'AZ&`&1EOG`X13!P_XH"%FKWPMY]0/Q6[2 M[7C7@ZG3KBO.)\VC#)QR>0E[>-5W$VM'Z=&L293X<,:=UZ4WOB>A0+I0@7?@ M"*5G(F2:\_6$;\N*/(D,98::*+GQ=C0%T00)W88H73$AHO'-;PJBR11XRX]0 M^E5"1,.[71]"DZ?Y/8XZ&_(X6*@SKO3M9YL3Z)%NHUIR1^FKEE0T-KH-L?1H M-PC.UWQAWN#PW=R#6U>]3_=1QBUEZ8TW*11(%RIT>Z(,O4LAC;T$*)`N7Z"W ML(]B!*20AAZ#.8PN6V//81_%+[3K+O2HC]#4,=C'F>.CJ-BD=V`\@3YLJ"%& ML16JH,8&N'TV=N;+@/RET.I*T$M_;=M]+^@G]T7;[E:GJZ6*S]]C:?;CV6S]*Z?671]?\\BWN;=1-Y:SM[M+RG+Y61J8>=9G96E-)R<4R_9+?=7"SBN:/;LSB MEH_*IK]!NY8VO1K4E6MKC7+>\>;-6KLS:==0NVM`7177H,SJJT9 MR@2&^K-['4R9%SRS.&&+,^_96W`C(C8BK6R/V5`Y;_@YVC7WA@M#7;M73)WC M%R1$%'^AYEBA2**5`6I&W2NKH@0BVP^6R.L@2XM0P'L4B"-*%5",O'U8KL/, MM`\4D9?BK9O[X_D\7`7)NA:/XY@EZMZM8"11KJ!FU`5X-25-=/O#%'DQ756B MKF^FC2!*4ZMUVVOI[.=>[.=>[.=>[.=>-N5I/_>R-;CV`2TE6?_=P+I0?9GM>&F;M`7'$VG!`*>;,O?HM;YJ[!T9V`;?QGM#O+-K9#+Z` M/\9B\$F,K0)I"U,86<1FR9B3\,JV4?AU%CU[<^8,[QR0=_O3R/)O?PFH\_'* MLJZCF;?T?#>Z"H.-JJ3IQ%Y42M-%H$ZX.PV73V'`+\U)LS?R&HRUT2*>;"6T MT(XZJ2[7,]R0O3F>/GNS=M0)=;F>T8;LS?'TV9NUX^Y8WXIX_S@WTL7Y+N3\ MGRN/^VUA"M.\?;!H9-WR'++D6^I'GC77`+U7A"&<*%/D>+7^XGIBGFXT9=[R M;A7%JIW*VXC M-XC373[>-'EIOSIY:5W&8%W(X/>BF#_LU*4-OIIBF+=D"B+6<)MD8LY8TGZ> MRS1IJ2FXD_X)>$,8OT#6T;REJA:A9,\!(_TA*K1N>^J/3?O8M(]-^]BTCTW[V+0/ MB>2#3?O8M$\)LDW[V+2/3?O8M(]-^]BTCTW[_,G2/E=AL9?IEE)`!V`*Z+\& M5^&@*--FA+YW=*U<4=5I:884F"&&6-MM4(F9Z,INQ>P>/'5U7^W41G0!$JSWU#GHE&*FI2H" M3!E"4Q!]I/5D'TJNJ:SA@OO&M&+/W`0"J\219ZOH1G9)0/]P'B*59!BC;!"O%'\(0#_L!\1!Y,BQ9(?[`+%P+$-TQ\*+AQQ+=K@/$`O',D1W+.*28(A]<"R93`D1 MW;'PXB''DAWN`\3"L0S1'0LO'G(LV>$^0"P2'>X#Q,*Q#-$= M"R\>F'8W$*QS+JP+$XL&-Q M^N%8G,*QC#IP+`[L6)Q^.!:G<"RC#AR+`SL6IQ^.Q2DIV@;I=H&X7J#(\5E:J9\7I5ZS;/9S; M=XS+U9;Q,ZQV@5M15['4AZX>TB:WZ3D<$V^*>,$!>BT9=VEY7H=UJ M&8CK%^,N=E4VR:AE=6]>G,E:=1TS+YBS M?*>#9MIJ?+^HJ^IQ5]+7]8!;9S2&]XN]83L-K#$EF_.S.;\22YOSLSD_F_.S M.3^;\[,Y/YOSLSD_F_.S.3^;\[,Y/YOSLSD_*..^=@Q'SOF0^$!MV,^=LSG3SSF\VYW;#&Z8Y@1K`L@]NSK)&+. M_U5'R%*!M^PE.>&__]7(4Q_LF0B,-43IQ7,_%+UG5>.9F[CG M/A,#&_'IE^G%\=7/Q_R?)Y?GL_/IQ?GL=OIE=JL;ESP2XY+YS^I')L6/#WZ7 M/Y^.3J9%#&09@ZR005:*'8JT0Y%V*-(.1=JA2#L4:84<9;J*N\\`GAG8Q!O,5ABG@+=956 MD1)>N'&8D&X<)FKCL$\.+]PX3$@W#A.U<3B@AO=H#\1;'*:(MU!72490PNO` M>!W2>)V.DQ<->,>3HT,`;_DP/;QE=94!'& M84@7;UE==;<,2GSA&21'I&>0'-5FD)#S;8=PU^R0=-?L4.V:.>2,VQCNFXU) M]\W&:M_,(>?LVAM]O8]+OMW'M_4;.N_W)9DB2,V]C M_2RT^F&2?-699PXQ]\8E0NZM?)@D7]6].<3LV\'!!'Z_34B_WR:U]QLQ_S8^ MVH/Z9^7#]/B6U>5Y"V)\)T>0OR@?)LBWI$[R)>??)G#[.R'=_D[4]G>([=_L M$@N[Q,(NL;!++.P2B_=98M%NWM*4/8@9:&Z07+E+=;:[/H3>B@J]3LP-U8NJ MUNS'JQZD!U!5B+E->J'L)^8NO.#!^#3GQ^D!U(A$W9_[^NXW7GW>,],SK!^F MA["N$76/[;SXF\A;NM&K:;T9$$>8:5WLMG?1;@=WQN9AL&B#5Q=)&+!.;C6S M\,Z(SU^>6!`;GG_U(#V0JL)JU@"'W94;1:ZH3-/-"<21):H36TT98!C,Q]#G M17YB+#YU==^+,`71PVI26DT3(#,-_=4RT'3@@3CZ9$MBJSF"=X;[V7WQEJOE MZ6JY\M,G)UT-);Y,_\"NN=.]ON?.F#=2_)TZ5X%O>"Z]2MCP`JK)A:XK)GFL M#'%9$)KV8?<"J@I.1BF7XP\#JX647S1S=F<2K9QV\JL9D&ZKQ-R$P6?TK@JJS1>*"ZT_L=?!E'G!,XL3 MMCCSGKT%"Q9B_7-E56Y#O;SAY\A6VANN2=8HBNF=L@5;IAUPWF,4(HJ_4$<1 MH4AZ]0#*E8AQ-F,J*X&@DL=8@$/QO>$%*/!P,O*%$8/KEFK)(OBFLK636SVQ:)G;\ZP2X">L^BF,\GO]SY45L(3Y4*%X?_`7?"+GE.?20MQ0N*P#%9S;2 M[@=:B".*J^3U^8OKB5Q*-&7>\FX5Q:E;,')MXFC&I[_H%>I7Q79X'(VU^D<_5$'W/*LI&"XZ70UT2]\?0>U$7C-<@:0G&5 M:WGR8;R-W$4V;',:+I=>'(N)D_I::3B%;$TTZ);T,==#QE.VIG02)H^?W3CA MQBL=.5O4YI6T.X4L_0;=DC[FBLJ8_]MW,U][?7\5!A&;KR(Q]=XX1VJC,^G6 M12OYLDI0[&AEK/Z*?1./YXF;KE($;O>9:&0LN@KF_*GU05TUN;/X[ M]*KK#1<;G&$2OPJ3 MTY`+\->:!*BS%;L-U2?=4`4;G$^W3C:X"%E)F*[[_,5=/OGP9B!J#%G8JE`) M%--FKS69!3V@>%#0Q;61)@K/72-/9ZP=-H5/2Q/1U\DT9%BN,-^T8-)Q*G7Z3_GRW MYFYKI7WG`3BK3W6A[U2,.W!W954M.ABZ\#Z!5SH>XP[L7TT.W`G1A?>.>-$Y M&7?A!E4Y<$=%%]X[XD4'9MR!&U3E-'1F=.%](U[JY(P[,(=MY]L!X=2)`[/O MQAT8R%,_C+W@H1WO>C!UVG7%DC7.YK1<7L(>7O7#I+6C]&C6)$I\*'Y2EM[H M=Z!`NE`A+X/B,*60?,;U:1C,^25%NF4H3<%T.9L4YU]%P?JVA_FK'H2;@(H\ MB0S%XXF2&Q]]4Q!-D,`C/T%Q<4)$8R_+%$23*="CFJ#X-"&BH1^E#Z')T]AG MFN!L9,HE7(8Q^QP&[%6#L72,)K^20`D.9WM2T;Z$P4*LL8R]>X\M9IS(2IU\ M8@ZCB5.O59)%L4Q"1EJCG]WH*TO$A!8-U%H$39XUF1(EBB/*:C2Y".)5Q!9G M[(FW-?Q77_E?)%ZRTFU7W.8,FJ@;94OT*&XJ;=NUV8G*$9HHU2S#!.V#?,;M M#-6#1,'5-RT\0C,\&F)4.15T4+S-B1N)-:')<;"X8=%]&"U=[DW3CZ/J76*; M$^B1;:-:[0;!$C2**2IIN0C2/PD\%[Z_BM-AF?AG-_+< M.\_WDM?K^^R::M\O_[[?(%TQFUR(K#`4WU72>!VD,UZNHTL6`W6BA)'&KFB5 M9''VE2ED'"\6GL#B^ED/_")8L!O'ZV;1^Y] M`-KU4-JDZWHE99Q=9_12?F%W,R\1]T$$-A_0.;WAK@J7%8#SJ?5"TXT;)V=A MNAJ'/W`>_W7V:<6O!;C=@5-(XP=T2_HHYE#V;>'^>@\ZY[4O#>^A&$19?&,_ M'`JD2Q7ZVO`>JL=A-LW-X71AFS7GR%'LY7$0K%P_TZL? M:]-&T`.KE9FS1'&0%0FF03A3$'&BF@\Z[Z&XO+**"_XR36OVK+Y;(!!'&ZTB M-J>+XO3*0AS>"P&@9H=IL\PTY@A1K)M2OCJ1OWZ8/$*GA!!G@Y5J^4,8X;`' M"(X:B$$,4>*>7OPPCW>X!POT#HX'S-H5J^NN"C?I@\ MPH,20A0/I)1_"",\[`'"PQ)"=$_#RQ_#",<]0#@N(42W,KS\"8QPT@.$DQ)" M=./"RS^"$1[U`.%1"2&Z.^$7!+F3[#!MA)G&'"&Z.^'E0^XD.TP>8C#MR)`[L3IP?NQ"FYDU$' M[L2!W8G3`W?BE-S)J`-WXL#NQ.F!.W%*[F34@3L9PNYDV`-W,BRYDQ&*.Y%S M=1NWGX$"Z6&%U.:`4;R+5-*P%XTYC"Y??W3%S=)WX]%\LE6WANPOS7FXC-F5A7<<,B+U0W#-G&#]*MKK=<55ZQ MJ(MXLFN*/X51JO8J3*Y3O8N+X"8*XR=^(;6==#8\EW)UM;H`63/[*`9.+->] M#<4L[DS>I8"NU(`AAAYI@]"<*.IZ(%6,9OH_'$J/+ZPWQXSB^4Q:6B+N$]X2 M6A0O^)/W\,CBY']67`N+_%=SRP!&T@,,RLT9HYC%?%6H5A+05D`GT"/>1G4. M'L5BPHHV@MX_X"78*&;T,OS6KB&!`NE!AM3F@%'-J%81T(H`\?1PMQ"=4T?U MJ5I!FQ#O'>T2:13CV&[7MAYMU=:T/YMS@&+[5!EB97_3S@4MSZ'/W"`\KP$4 MFZB**FWCQ!^_X*'VU?;3Z%>$67M>%=C;%J:ZK@.6#@]?WQ_? M\XX75S9[#+^IO##-=:5_K<1@TU`9Q'ORX` M\7EMH/C:VM.ZP2["QA/H\X=V,SO`WNPP593GV[-DHWZ+79G2^KXD+4Z1]"O_ M?:X[OWTZ\>N-LU#:G-"CJM,\MX>=&/J&V2G-X?2AFV>K'.),W'WFW?<'UF(S M0B"0'F9(;0X89UJO1HEQAT(XMA^8-?L5'N+,_JV+T65IS&&]X*MD:`YQ9@77 M=<@/RS>QE7&]@"O%YG1Q)@P;A-06HICC^D.WM#3E$&>EHUY(?=6H.:XW=,OK M2`]Q%D'6A_WENUF;(:WPO:JNB<.LZZR;H@<(?>QO!>,#?LUWN(8@I+ MWT*?T M`KI.>%X#*);Q]M&+DE?X+6F(H4?8(#0GBF(3%1&F]Z`YC#Q7W3L/Q2-6=>C> M=-H(ZD#5MQJ*(ZQ*`#'2)UB"AV+L\M(;WU9@)&&LX)OI>YS<_#E.G!3EGO@> MLP"9_M6OL]73D\^6O!A3`DD;08^=5F;Q`3:!C&O-9OY<9E=FU)(*X=;Z+HQ9 M9=C[A]WR]5[RLK._5O^V@H'+8<&BF&)5`_&;._\:A\''>;C,BCX+YRMQ)<45 M%U?W)4CKA2U.OTPOCJ]^/N;_/+D\GYU/+\YGM],OL]N(@O;X_YR]PR7!\5/#W[/?_P/'I05,)`E#+(B!ED9[YSCS%?)IOD_-:6I'GWG M]L9\XY6^PZX&=/&$&+#)3[*K$O.GP[8GF[8G[]B<_+`K--RY,>/_\?]02P,$ M%`````@`N60Z0+V-0=7@+``$$)0X```0Y`0``[5EK;]LV%/T^8/^!T^?*LI(V ME@*[11[.$,!-"\?9`@Q#04NTPX8B59)*'!3[[R,IR4])L1)G$#`G0"+KDN<< M\AY=4F;WTRPBX`%Q@1GM66ZK;0%$`Q9B.NU9B;"A"#"V/GW\]9?N;[9]>SH< M@)`%282H!`%'4*(0C)_`<`C.&:6($/0$+C^#KYP%2`C&P?M66_^"1"A(<)%\ MQU(DX))*Q2GA%(';/R$-;5LSB.`.11!(R*=(7L$(B1@&J&?=21D?.\[CXV/K M.PSN!:.M@$7.0=L]:/NNEDR05G3!>'2.)C`ALF?]2"#!$XQ""Z@Q4K$"\WC8 M8GRJ$-JN<_MY<&V(LX;'P8.0[A:L:>L9P?2^"-SU?=\QT;SI1LO9F)-TS5#-)@WIZJ#"11<8=0A"2IF$ M4AG`?-9WXAC3"9:;0SJ?J M6\Q12VG,VT@LB>KXE2.ALF:HP4`%Q#L`R;P59P15C%Z'G7@)8K#0ET-`'FR@ M;&1'@;`8<8F16$J!L[O1!Y`4C/X,DB`AKQE\L$!H[-A#-"D8NWI(,<6O&'HX M!VCLR`D<%XQ\`,>(O'#01/=]V_%JG)$:(=`7-\/+TBIH!)UG*T'^7Q7R/E4# M?;I4U8-'QID6P*%*^#8MYUIR-8LL?VR;'V"#'&'Y4J&!%`XLX76==9!U_$2@ M\`O]:*[7*TG6.VM2U7/M,=R^XZJ)B_ME=_.\["1=0RSNAT@FG%XG403YTPTU MUD+A6<(QI.=/%$8XT,U.P@=(]3)MGTRG:H8$?D`7"0U7L_H2P#6\YW+ONJNY MUUA.R@DR4O!S3ON/:I%2@XS;=`!S=A5?"`!:P=XM:V[1>Z(P(>CZ#G)TQTB( M^`5"HJ9%:J/4]<6!2F5.HB\7/$`3[8VP,R. MKQHE(P09(_BYX-PO+V]EDRLV1"&*8JUCQY:I"UW7/A\J[?,.7#&P$+!WTUNN M42,F(4DWA]LO3:>0GZG-@RQ:HK8#+,%[UCE'A2N4X009:7V+@+]R`7_OW5+F ME@>U_D\+7==XY2_4 M*>?^?7JW5L$B($PD'*TG]QQ*V$]/,,29PCFY^N-$_3T=]*_[P\O^]6AXO MPWC6!NWRXK`@6B\0_T\3=)WEXS+U:?4XK8NCF'$):.%Q9MF!7GH2.F"!`:KH MHC_9>3];W[+=`_O0;"'F%Z-%!/0MZOM@2#)5#0FK(')T38G*_: M;5)I83&'6-\V8^FQ5WK"?!RR"&)Z*5&DGP.E,QD+ MB66B5?[.61+W+'-V?8Q5$PM`%>4PD#UK`HFV%L5$U0U]8B5YHD_13.-8:6?A MR!"%"<].CPJUGYD:Y?G>^TWMF[%F:<_G]L@KG_=%K)G:.WZ%9_QF:_!6>\1KN&;]=KGT1:ZAVMT*[VV3M'<\_*M.^'&NH]M(ZLQQK MHG;EBX,*SQPT7'O%?L9OZ'YFONY7U,BCAM?(3D6-[#2\1G8J:F2GT352Z:MX M5CL-?U8[!?OWS5A#M9>N368XW4[OFE]7TYUD3M MRA<5?O>:ZO?Y=Y4C-).GA`7W*_*+PBLCD/G]_VX072?]VD==_@M02P$"'@,4 M````"`"Y9#I!S?(F43T1``"H_P$`$@`8```````!````I($`````8W9S=#$M M,C`Q,C`Y,3`N>&UL550%``->+V-0=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`N60Z07F".^+[`@``%1,``!8`&````````0```*2!B1$``&-V`L``00E#@``!#D!``!02P$"'@,4 M````"`"Y9#I!\;9G<2$G```8M@,`%@`8```````!````I('4%```8W9S=#$M M,C`Q,C`Y,3!?9&5F+GAM;%54!0`#7B]C4'5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`+ED.D'?[KE#(2@``"IN`@`6`!@```````$```"D@44\``!C=G-T M,2TR,#$R,#DQ,%]L86(N>&UL550%``->+V-0=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`N60Z0;NFY;6[(```PX4"`!8`&````````0```*2!MF0``&-V M`L``00E#@``!#D!``!0 M2P$"'@,4````"`"Y9#I!S`?0\*L%``">,0``$@`8```````!````I('!A0`` M8W9S=#$M,C`Q,C`Y,3`N>'-D550%``->+V-0=7@+``$$)0X```0Y`0``4$L% 3!@`````&``8`(`(``+B+```````` ` end XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 23 9 1 false 22 0 false 0 false false R1.htm 000000 - Document - Document and Entity Information Sheet http://www.jackson.com/role/DocumentDocumentandEntityInformation Document and Entity Information false false R2.htm 000010 - Document - Risk/Return Supplement {Unlabeled} - CURIAN VARIABLE SERIES TRUST Sheet http://www.jackson.com/role/DocumentRiskReturnSupplementUnlabeledCURIANVARIABLESERIESTRUST Risk/Return Supplement - CURIAN VARIABLE SERIES TRUST false false R3.htm 000019 - Disclosure - Risk/Return Detail Data {Elements} - CURIAN VARIABLE SERIES TRUST Sheet http://www.jackson.com/role/DisclosureRiskReturnDetailDataElementsCURIANVARIABLESERIESTRUST Risk/Return Detail Data - CURIAN VARIABLE SERIES TRUST false false R4.htm 040000 - Disclosure - Risk/Return Detail Data {Elements} Sheet http://xbrl.sec.gov/rr/role/RiskReturnDetailData Risk/Return Detail Data true false All Reports Book All Reports cvst1-20120910.xml cvst1-20120910.xsd cvst1-20120910_cal.xml cvst1-20120910_def.xml cvst1-20120910_lab.xml cvst1-20120910_pre.xml true true